-- =============================================================
-- AnesIA — Schema completo para novo projeto Supabase
-- Colar este ficheiro no SQL Editor do Supabase e clicar "Run"
-- =============================================================


-- ── 1. ROLES & FUNÇÕES BASE ───────────────────────────────────

CREATE TYPE public.app_role AS ENUM ('admin', 'moderator', 'user');

CREATE TABLE public.user_roles (
  id uuid PRIMARY KEY DEFAULT gen_random_uuid(),
  user_id uuid REFERENCES auth.users(id) ON DELETE CASCADE NOT NULL,
  role app_role NOT NULL,
  UNIQUE (user_id, role)
);
ALTER TABLE public.user_roles ENABLE ROW LEVEL SECURITY;

CREATE OR REPLACE FUNCTION public.has_role(_user_id uuid, _role app_role)
RETURNS boolean LANGUAGE sql STABLE SECURITY DEFINER SET search_path = public AS $$
  SELECT EXISTS (SELECT 1 FROM public.user_roles WHERE user_id = _user_id AND role = _role)
$$;

CREATE POLICY "Users can view own roles" ON public.user_roles
  FOR SELECT TO authenticated USING (auth.uid() = user_id);
CREATE POLICY "Admins can manage roles" ON public.user_roles
  FOR ALL TO authenticated USING (public.has_role(auth.uid(), 'admin'));

CREATE OR REPLACE FUNCTION public.update_updated_at_column()
RETURNS TRIGGER AS $$ BEGIN NEW.updated_at = now(); RETURN NEW; END; $$
LANGUAGE plpgsql SET search_path = public;


-- ── 2. PROCEDURES ─────────────────────────────────────────────

CREATE TABLE public.procedures (
  id text PRIMARY KEY,
  specialty text NOT NULL,
  specialties jsonb NOT NULL DEFAULT '[]',
  titles jsonb NOT NULL,
  synonyms jsonb DEFAULT '{}',
  content jsonb NOT NULL,
  tags jsonb DEFAULT '[]',
  is_pro boolean NOT NULL DEFAULT false,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.procedures ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read procedures" ON public.procedures FOR SELECT USING (true);
CREATE POLICY "Admin write procedures" ON public.procedures FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update procedures" ON public.procedures FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete procedures" ON public.procedures FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE INDEX idx_procedures_specialty ON public.procedures(specialty);
CREATE TRIGGER update_procedures_updated_at BEFORE UPDATE ON public.procedures FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 3. DRUGS ──────────────────────────────────────────────────

CREATE TABLE public.drugs (
  id text PRIMARY KEY,
  names jsonb NOT NULL,
  class text,
  dosing jsonb NOT NULL DEFAULT '{}',
  notes jsonb DEFAULT '{}',
  contraindications jsonb DEFAULT '[]',
  tags jsonb DEFAULT '[]',
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.drugs ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read drugs" ON public.drugs FOR SELECT USING (true);
CREATE POLICY "Admin write drugs" ON public.drugs FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update drugs" ON public.drugs FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete drugs" ON public.drugs FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE TRIGGER update_drugs_updated_at BEFORE UPDATE ON public.drugs FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 4. GUIDELINES ─────────────────────────────────────────────

CREATE TABLE public.guidelines (
  id text PRIMARY KEY,
  category text NOT NULL,
  titles jsonb NOT NULL,
  items jsonb NOT NULL,
  refs jsonb DEFAULT '[]',
  tags jsonb DEFAULT '[]',
  specialties jsonb NOT NULL DEFAULT '[]',
  organization text,
  recommendation_strength integer NOT NULL DEFAULT 0,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.guidelines ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read guidelines" ON public.guidelines FOR SELECT USING (true);
CREATE POLICY "Admin write guidelines" ON public.guidelines FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update guidelines" ON public.guidelines FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete guidelines" ON public.guidelines FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE INDEX idx_guidelines_category ON public.guidelines(category);
CREATE TRIGGER update_guidelines_updated_at BEFORE UPDATE ON public.guidelines FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 5. PROTOCOLES ─────────────────────────────────────────────

CREATE TABLE public.protocoles (
  id text PRIMARY KEY,
  category text NOT NULL,
  titles jsonb NOT NULL,
  steps jsonb NOT NULL,
  refs jsonb DEFAULT '[]',
  tags jsonb DEFAULT '[]',
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.protocoles ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read protocoles" ON public.protocoles FOR SELECT USING (true);
CREATE POLICY "Admin write protocoles" ON public.protocoles FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update protocoles" ON public.protocoles FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete protocoles" ON public.protocoles FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE INDEX idx_protocoles_category ON public.protocoles(category);
CREATE TRIGGER update_protocoles_updated_at BEFORE UPDATE ON public.protocoles FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 6. ALR BLOCKS ─────────────────────────────────────────────

CREATE TABLE public.alr_blocks (
  id text PRIMARY KEY,
  region text NOT NULL,
  titles jsonb NOT NULL,
  indications jsonb DEFAULT '{}',
  contraindications jsonb DEFAULT '{}',
  technique jsonb DEFAULT '{}',
  drugs jsonb DEFAULT '{}',
  tags jsonb DEFAULT '[]',
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.alr_blocks ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read alr_blocks" ON public.alr_blocks FOR SELECT USING (true);
CREATE POLICY "Admin write alr_blocks" ON public.alr_blocks FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update alr_blocks" ON public.alr_blocks FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete alr_blocks" ON public.alr_blocks FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE INDEX idx_alr_blocks_region ON public.alr_blocks(region);
CREATE TRIGGER update_alr_blocks_updated_at BEFORE UPDATE ON public.alr_blocks FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 7. SPECIALTIES ────────────────────────────────────────────

CREATE TABLE public.specialties (
  id text PRIMARY KEY,
  name jsonb NOT NULL DEFAULT '{}',
  synonyms jsonb DEFAULT '[]',
  is_active boolean DEFAULT true,
  sort_base integer DEFAULT 0,
  created_at timestamptz DEFAULT now(),
  updated_at timestamptz DEFAULT now()
);
ALTER TABLE public.specialties ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read specialties" ON public.specialties FOR SELECT USING (true);
CREATE POLICY "Admin write specialties" ON public.specialties FOR INSERT WITH CHECK (public.has_role(auth.uid(), 'admin'::app_role));
CREATE POLICY "Admin update specialties" ON public.specialties FOR UPDATE USING (public.has_role(auth.uid(), 'admin'::app_role));
CREATE POLICY "Admin delete specialties" ON public.specialties FOR DELETE USING (public.has_role(auth.uid(), 'admin'::app_role));
CREATE TRIGGER update_specialties_updated_at BEFORE UPDATE ON public.specialties FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();

INSERT INTO public.specialties (id, name, sort_base) VALUES
  ('chirurgie-generale', '{"fr":"Chirurgie générale","en":"General Surgery","pt":"Cirurgia Geral"}', 1),
  ('orthopedie', '{"fr":"Orthopédie","en":"Orthopedics","pt":"Ortopedia"}', 2),
  ('urologie', '{"fr":"Urologie","en":"Urology","pt":"Urologia"}', 3),
  ('gynecologie', '{"fr":"Gynécologie","en":"Gynecology","pt":"Ginecologia"}', 4),
  ('orl', '{"fr":"ORL","en":"ENT","pt":"ORL"}', 5),
  ('neurochirurgie', '{"fr":"Neurochirurgie","en":"Neurosurgery","pt":"Neurocirurgia"}', 6),
  ('obstetrique', '{"fr":"Obstétrique","en":"Obstetrics","pt":"Obstetrícia"}', 7);


-- ── 8. IMPORT LOGS & HOSPITAL PROFILES ───────────────────────

CREATE TABLE public.procedure_translations (
  id uuid PRIMARY KEY DEFAULT gen_random_uuid(),
  procedure_id text NOT NULL REFERENCES public.procedures(id) ON DELETE CASCADE,
  lang text NOT NULL CHECK (lang IN ('en', 'pt')),
  section text NOT NULL DEFAULT 'quick' CHECK (section IN ('title', 'quick', 'deep')),
  translated_content jsonb NOT NULL,
  generated_at timestamptz NOT NULL DEFAULT now(),
  review_status text NOT NULL DEFAULT 'pending' CHECK (review_status IN ('pending', 'approved', 'rejected')),
  reviewed_at timestamptz,
  reviewed_by uuid REFERENCES auth.users(id) ON DELETE SET NULL,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now(),
  UNIQUE (procedure_id, lang, section)
);
ALTER TABLE public.procedure_translations ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read procedure_translations" ON public.procedure_translations FOR SELECT USING (true);
CREATE POLICY "Admin insert procedure_translations" ON public.procedure_translations FOR INSERT TO authenticated WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update procedure_translations" ON public.procedure_translations FOR UPDATE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete procedure_translations" ON public.procedure_translations FOR DELETE TO authenticated USING (public.has_role(auth.uid(), 'admin'));
CREATE INDEX idx_guidelines_strength ON public.guidelines(recommendation_strength DESC);
CREATE INDEX idx_procedure_translations_lookup ON public.procedure_translations(procedure_id, lang, section, review_status);
CREATE TRIGGER update_procedure_translations_updated_at BEFORE UPDATE ON public.procedure_translations FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();

CREATE TABLE public.import_logs (
  id uuid PRIMARY KEY DEFAULT gen_random_uuid(),
  user_id uuid REFERENCES auth.users(id) ON DELETE SET NULL,
  total integer NOT NULL DEFAULT 0,
  success integer NOT NULL DEFAULT 0,
  failed integer NOT NULL DEFAULT 0,
  errors jsonb DEFAULT '[]'::jsonb,
  created_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.import_logs ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Admins can manage import_logs" ON public.import_logs FOR ALL USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admins can insert import_logs" ON public.import_logs FOR INSERT WITH CHECK (public.has_role(auth.uid(), 'admin'));

CREATE TABLE public.hospital_profiles (
  id text PRIMARY KEY,
  name text NOT NULL,
  settings jsonb DEFAULT '{}'::jsonb,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.hospital_profiles ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read hospital_profiles" ON public.hospital_profiles FOR SELECT USING (true);
CREATE POLICY "Admin write hospital_profiles" ON public.hospital_profiles FOR INSERT WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update hospital_profiles" ON public.hospital_profiles FOR UPDATE USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete hospital_profiles" ON public.hospital_profiles FOR DELETE USING (public.has_role(auth.uid(), 'admin'));
CREATE TRIGGER update_hospital_profiles_updated_at BEFORE UPDATE ON public.hospital_profiles FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 9. PLANS & USER ENTITLEMENTS ─────────────────────────────

CREATE TABLE public.plans (
  id text PRIMARY KEY,
  name text NOT NULL,
  features jsonb DEFAULT '{}'::jsonb,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now()
);
ALTER TABLE public.plans ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Public read plans" ON public.plans FOR SELECT USING (true);
CREATE POLICY "Admin write plans" ON public.plans FOR INSERT WITH CHECK (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin update plans" ON public.plans FOR UPDATE USING (public.has_role(auth.uid(), 'admin'));
CREATE POLICY "Admin delete plans" ON public.plans FOR DELETE USING (public.has_role(auth.uid(), 'admin'));
CREATE TRIGGER update_plans_updated_at BEFORE UPDATE ON public.plans FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();

INSERT INTO public.plans (id, name, features) VALUES
  ('free', 'Free', '{"max_procedures": 10, "scores": false, "advanced_dose": false}'::jsonb),
  ('pro', 'Pro', '{"max_procedures": -1, "scores": true, "advanced_dose": true}'::jsonb);

CREATE TABLE public.user_entitlements (
  id uuid PRIMARY KEY DEFAULT gen_random_uuid(),
  user_id uuid NOT NULL REFERENCES auth.users(id) ON DELETE CASCADE,
  plan_id text NOT NULL REFERENCES public.plans(id) DEFAULT 'free',
  active boolean NOT NULL DEFAULT true,
  expires_at timestamptz,
  created_at timestamptz NOT NULL DEFAULT now(),
  updated_at timestamptz NOT NULL DEFAULT now(),
  UNIQUE (user_id)
);
ALTER TABLE public.user_entitlements ENABLE ROW LEVEL SECURITY;
-- RLS com verificação de expiração no servidor (seguro)
CREATE POLICY "Users read own entitlement" ON public.user_entitlements
  FOR SELECT USING (
    auth.uid() = user_id
    AND active = true
    AND (expires_at IS NULL OR expires_at > now())
  );
CREATE POLICY "Admin manage entitlements" ON public.user_entitlements FOR ALL USING (public.has_role(auth.uid(), 'admin'));
CREATE TRIGGER update_entitlements_updated_at BEFORE UPDATE ON public.user_entitlements FOR EACH ROW EXECUTE FUNCTION public.update_updated_at_column();


-- ── 10. USER PROFILES ─────────────────────────────────────────

CREATE TABLE IF NOT EXISTS public.user_profiles (
  user_id uuid PRIMARY KEY REFERENCES auth.users(id) ON DELETE CASCADE,
  email text,
  name text,
  created_at timestamptz DEFAULT now()
);
ALTER TABLE public.user_profiles ENABLE ROW LEVEL SECURITY;
CREATE POLICY "Users read own profile" ON public.user_profiles FOR SELECT USING (auth.uid() = user_id);
CREATE POLICY "Users update own profile" ON public.user_profiles FOR UPDATE USING (auth.uid() = user_id);
CREATE POLICY "Users insert own profile" ON public.user_profiles FOR INSERT WITH CHECK (auth.uid() = user_id);


-- ── 11. SEED DRUGS (20 fármacos de anestesia) ────────────────

INSERT INTO public.drugs (id, names, dosing, notes, contraindications) VALUES

('paracetamol',
 '{"fr":"Paracétamol","pt":"Paracetamol","en":"Acetaminophen"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie","route":"IV","mg_per_kg":15,"max_mg":1000,"notes":["Intervalle minimum 6h entre doses","Max 60 mg/kg/j ou 4g/j"]}],"concentrations":[{"label":"IV 10 mg/mL","mg_per_ml":10}]}'::jsonb,
 '{"renal_hepatic_notes":["IHC : max 2g/j","IRC sévère : espacer les prises (intervalle 8h)"]}'::jsonb,
 '["Insuffisance hépatique sévère","Allergie connue"]'::jsonb),

('ibuprofene',
 '{"fr":"Ibuprofène","pt":"Ibuprofeno","en":"Ibuprofen"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie","route":"PO / IV","mg_per_kg":10,"max_mg":400,"notes":["Intervalle 6-8h","CI si insuffisance rénale, ulcère GD, grossesse T3"]}],"concentrations":[]}'::jsonb,
 '{"renal_hepatic_notes":["Éviter si DFG < 30 mL/min","CI si IHC sévère"]}'::jsonb,
 '["Insuffisance rénale sévère","Ulcère gastroduodénal actif","Grossesse 3e trimestre","Allergie AINS/aspirine"]'::jsonb),

('ketorolac',
 '{"fr":"Kétorolac","pt":"Cetorolac","en":"Ketorolac"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie","route":"IV","mg_per_kg":0.5,"max_mg":30,"notes":["Durée max 48h IV","Sujet âgé > 65 ans : max 15 mg/dose"]}],"concentrations":[{"label":"30 mg/mL","mg_per_ml":30}]}'::jsonb,
 '{"renal_hepatic_notes":["CI si DFG < 30 mL/min","Réduire dose > 65 ans : max 15 mg"]}'::jsonb,
 '["Insuffisance rénale","Risque hémorragique élevé","Ulcère GD actif"]'::jsonb),

('morphine',
 '{"fr":"Morphine","pt":"Morfina","en":"Morphine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie_postop","route":"IV titration","mg_per_kg":0.1,"max_mg":10,"notes":["Titration : bolus 2-3 mg /5 min","Objectif EVA < 3/10","Surveillance respiratoire obligatoire"]},{"indication_tag":"analgésie_secours","route":"IV titration","mg_per_kg":0.05,"max_mg":5,"notes":["Dose réduite enfant/sujet âgé","Titration prudente par bolus 1 mg"]}],"concentrations":[{"label":"1 mg/mL (dilué)","mg_per_ml":1},{"label":"10 mg/mL","mg_per_ml":10}]}'::jsonb,
 '{"renal_hepatic_notes":["IRC : accumulation M6G → réduire dose et espacer","IHC : réduire dose"]}'::jsonb,
 '["Insuffisance respiratoire sévère","SAOS non appareillé (prudence)","Obstruction intestinale"]'::jsonb),

('ketamine',
 '{"fr":"Kétamine","pt":"Cetamina","en":"Ketamine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"co-analgésie","route":"IV","mg_per_kg":0.25,"max_mg":25,"notes":["Dose sub-anesthésique (anti-hyperalgésique)","Perfusion relais : 0.1-0.2 mg/kg/h","Intérêt : terrain douleur chronique, opioïdes long cours"]}],"concentrations":[{"label":"10 mg/mL","mg_per_ml":10},{"label":"50 mg/mL","mg_per_ml":50}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement habituel"]}'::jsonb,
 '["HTA non contrôlée","HTIC","Éclampsie","Psychose (CI relative)"]'::jsonb),

('lidocaine',
 '{"fr":"Lidocaïne","pt":"Lidocaína","en":"Lidocaine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie_IV","route":"IV","mg_per_kg":1.5,"max_mg":200,"notes":["Bolus à l''induction","Effet anti-hyperalgésique et épargne morphinique","Perfusion possible : 1-2 mg/kg/h"]},{"indication_tag":"BIS_adjuvant","route":"Péri-nerveux","mg_per_kg":5,"max_mg":300,"notes":["Dose max avec adrénaline : 7 mg/kg","Mélange avec bupivacaïne : onset rapide"]}],"concentrations":[{"label":"1% (10 mg/mL)","mg_per_ml":10},{"label":"2% (20 mg/mL)","mg_per_ml":20}]}'::jsonb,
 '{"renal_hepatic_notes":["Réduire si IHC sévère (métabolisme hépatique)"]}'::jsonb,
 '["BAV non appareillé","Allergie aux amides","Porphyrie"]'::jsonb),

('propofol',
 '{"fr":"Propofol","pt":"Propofol","en":"Propofol"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"induction","route":"IV","mg_per_kg":2,"max_mg":300,"notes":["Injection lente 30-60s","Réduire chez sujet âgé/hypovolémique : 1-1.5 mg/kg","Douleur injection : lidocaïne 20-40 mg IV avant"]},{"indication_tag":"induction_ISR","route":"IV","mg_per_kg":2,"max_mg":300,"notes":["Induction séquence rapide","Ne pas réduire la dose en ISR"]},{"indication_tag":"induction_AG","route":"IV","mg_per_kg":2,"max_mg":300,"notes":["AG si échec/CI rachianesthésie"]}],"concentrations":[{"label":"1% (10 mg/mL)","mg_per_ml":10},{"label":"2% (20 mg/mL)","mg_per_ml":20}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement nécessaire"]}'::jsonb,
 '["Allergie soja/œuf (controversé, très rare)","Choc hypovolémique non réanimé"]'::jsonb),

('sufentanil',
 '{"fr":"Sufentanil","pt":"Sufentanil","en":"Sufentanil"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie_perop","route":"IV","mg_per_kg":null,"max_mg":null,"notes":["Bolus : 0.2-0.5 µg/kg à l''induction","Entretien : 0.15-0.7 µg/kg/h","5-10× plus puissant que le fentanyl"],"unit_override":"µg"},{"indication_tag":"analgésie_IT","route":"IT","mg_per_kg":null,"max_mg":null,"notes":["2.5-5 µg IT (adjuvant rachianesthésie)","Attention dépression respiratoire tardive (surveillance ≥ 12h)"],"unit_override":"µg"}],"concentrations":[{"label":"5 µg/mL","mg_per_ml":0.005},{"label":"50 µg/mL","mg_per_ml":0.05}]}'::jsonb,
 '{"renal_hepatic_notes":["Réduire si IHC","IRC : accumulation possible"]}'::jsonb,
 '["Dépression respiratoire sévère","Insuffisance respiratoire aiguë"]'::jsonb),

('fentanyl',
 '{"fr":"Fentanyl","pt":"Fentanil","en":"Fentanyl"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"analgésie_perop","route":"IV","mg_per_kg":null,"max_mg":null,"notes":["Bolus : 1-3 µg/kg à l''induction","Entretien : 0.5-2 µg/kg/h","Délai d''action : 2-3 min"],"unit_override":"µg"},{"indication_tag":"analgésie_IT","route":"IT","mg_per_kg":null,"max_mg":null,"notes":["10-25 µg IT (adjuvant rachianesthésie)","Surveillance dépression respiratoire 12-24h"],"unit_override":"µg"}],"concentrations":[{"label":"50 µg/mL","mg_per_ml":0.05}]}'::jsonb,
 '{"renal_hepatic_notes":["IRC : accumulation possible — réduire dose","IHC : réduire dose"]}'::jsonb,
 '["Dépression respiratoire sévère","Insuffisance respiratoire aiguë"]'::jsonb),

('remifentanil',
 '{"fr":"Rémifentanil","pt":"Remifentanil","en":"Remifentanil"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"TIVA","route":"IVSE","mg_per_kg":null,"max_mg":null,"notes":["Induction : 0.5-1 µg/kg/min (réduire si hémodynamique instable)","Entretien : 0.1-0.5 µg/kg/min","Arrêter 5 min avant fin de chirurgie — prévoir relais antalgique"],"unit_override":"µg/kg/min"}],"concentrations":[{"label":"50 µg/mL (dilué)","mg_per_ml":0.05}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement — métabolisme plasmatique (estérases)"]}'::jsonb,
 '["Dépression respiratoire sévère","Pas d''utilisation en bolus pur (rigidité thoracique)"]'::jsonb),

('midazolam',
 '{"fr":"Midazolam","pt":"Midazolam","en":"Midazolam"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"prémédication","route":"IV","mg_per_kg":0.02,"max_mg":5,"notes":["Effet anxiolytique et amnésiant","Réduire chez sujet âgé : 0.01-0.015 mg/kg","Titrer selon effet"]},{"indication_tag":"induction","route":"IV","mg_per_kg":0.15,"max_mg":7.5,"notes":["Induction seule possible mais lente (2-3 min)","Synergie avec propofol : réduire les doses des deux"]}],"concentrations":[{"label":"1 mg/mL","mg_per_ml":1},{"label":"5 mg/mL","mg_per_ml":5}]}'::jsonb,
 '{"renal_hepatic_notes":["IHC sévère : demi-vie prolongée — réduire dose","IRC : accumulation métabolites actifs"]}'::jsonb,
 '["Myasthénie","Insuffisance respiratoire sévère","Glaucome à angle fermé","Allergie benzodiazépines"]'::jsonb),

('etomidate',
 '{"fr":"Étomidate","pt":"Etomidato","en":"Etomidate"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"induction","route":"IV","mg_per_kg":0.3,"max_mg":30,"notes":["Induction hémodynamiquement stable","Privilégier chez patient à risque cardiovasculaire ou hypovolémique","Myoclonies fréquentes (prétraitement midazolam 0.03 mg/kg)","Injection douloureuse — voie de gros calibre"]},{"indication_tag":"induction_ISR","route":"IV","mg_per_kg":0.3,"max_mg":30,"notes":["Alternative à propofol en ISR pour patient instable"]}],"concentrations":[{"label":"2 mg/mL","mg_per_ml":2}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement nécessaire habituellement"]}'::jsonb,
 '["Insuffisance surrénalienne connue (CI relative)","Usage prolongé CI (inhibition cortisol)"]'::jsonb),

('rocuronium',
 '{"fr":"Rocuronium","pt":"Rocurônio","en":"Rocuronium"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"intubation","route":"IV","mg_per_kg":0.6,"max_mg":null,"notes":["Délai d''action 60-90s","Durée 30-40 min"]},{"indication_tag":"ISR","route":"IV","mg_per_kg":1.2,"max_mg":null,"notes":["Dose ISR : 1.2 mg/kg","Délai 45-60s","Réversible par sugammadex 16 mg/kg si échec intubation"]}],"concentrations":[{"label":"10 mg/mL","mg_per_ml":10}]}'::jsonb,
 '{"renal_hepatic_notes":["IHC sévère : durée d''action prolongée"]}'::jsonb,
 '["Allergie connue aux curares (rare)"]'::jsonb),

('sugammadex',
 '{"fr":"Sugammadex","pt":"Sugamadex","en":"Sugammadex"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"reversal","route":"IV","mg_per_kg":2,"max_mg":null,"notes":["Réversion bloc modéré (TOF ≥ 2)","Vérifier TOF avant administration"]},{"indication_tag":"reversal_profond","route":"IV","mg_per_kg":4,"max_mg":null,"notes":["Réversion bloc profond (PTC ≥ 1)"]},{"indication_tag":"reversal_urgence","route":"IV","mg_per_kg":16,"max_mg":null,"notes":["Réversion immédiate (can''t intubate can''t ventilate)","Dose unique, injection rapide"]}],"concentrations":[{"label":"100 mg/mL","mg_per_ml":100}]}'::jsonb,
 '{"renal_hepatic_notes":["CI si DFG < 30 mL/min (élimination rénale)","Non dialysable efficacement"]}'::jsonb,
 '["Allergie connue (très rare, anaphylaxie décrite)"]'::jsonb),

('sevoflurane',
 '{"fr":"Sévoflurane","pt":"Sevoflurano","en":"Sevoflurane"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"entretien","route":"INH","mg_per_kg":null,"max_mg":null,"notes":["MAC adulte ≈ 2.0%","MAC enfant ≈ 2.5%","Titrer selon BIS/entropie","Réduire MAC avec opioïdes (≈ 0.7-1.0 MAC)"],"unit_override":"MAC"}],"concentrations":[]}'::jsonb,
 '{"renal_hepatic_notes":["Néphrotoxicité théorique Compound A (bas débit) — controversé"]}'::jsonb,
 '["Hyperthermie maligne (ATCD personnel ou familial)","Myopathie sensible aux halogénés"]'::jsonb),

('bupivacaine',
 '{"fr":"Bupivacaïne","pt":"Bupivacaína","en":"Bupivacaine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"rachianesthésie","route":"IT","mg_per_kg":null,"max_mg":null,"notes":["Bupivacaïne hyperbare 0.5% : 10-15 mg selon chirurgie","Dose fixe (non basée sur le poids)","Ajuster selon taille et niveau souhaité"],"unit_override":"mg (dose fixe)"},{"indication_tag":"BIS","route":"Péri-nerveux","mg_per_kg":2,"max_mg":150,"notes":["Dose max sans adrénaline : 2 mg/kg","Dose max avec adrénaline : 3 mg/kg","Durée bloc : 6-12h"]}],"concentrations":[{"label":"0.25% (2.5 mg/mL)","mg_per_ml":2.5},{"label":"0.5% (5 mg/mL)","mg_per_ml":5},{"label":"0.5% hyperbare","mg_per_ml":5}]}'::jsonb,
 '{"renal_hepatic_notes":["Réduire si IHC sévère"]}'::jsonb,
 '["Allergie aux amides","Infection site de ponction","Troubles coagulation (blocs centraux)"]'::jsonb),

('ondansetron',
 '{"fr":"Ondansétron","pt":"Ondansetron","en":"Ondansetron"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"PONV","route":"IV","mg_per_kg":0.1,"max_mg":4,"notes":["Administrer en fin d''intervention","Peut prolonger QTc — ECG si facteurs de risque"]}],"concentrations":[{"label":"2 mg/mL","mg_per_ml":2}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement rénal","IHC sévère : max 8 mg/j"]}'::jsonb,
 '["QT long congénital","Utilisation concomitante d''apomorphine"]'::jsonb),

('dexamethasone',
 '{"fr":"Dexaméthasone","pt":"Dexametasona","en":"Dexamethasone"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"PONV_anti-oedème","route":"IV","mg_per_kg":0.15,"max_mg":8,"notes":["Administrer à l''induction","Double effet : anti-émétique + anti-inflammatoire","Attention diabétiques : hyperglycémie transitoire"]}],"concentrations":[{"label":"4 mg/mL","mg_per_ml":4}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement habituel"]}'::jsonb,
 '["Infection systémique non contrôlée","Diabète non équilibré (CI relative)"]'::jsonb),

('ephedrine',
 '{"fr":"Éphédrine","pt":"Efedrina","en":"Ephedrine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"hypotension","route":"IV bolus","mg_per_kg":null,"max_mg":null,"notes":["Bolus 6-12 mg IV (titrer par 3-6 mg)","Effet mixte α+β : ↑ PA et FC","Max cumulé ≈ 30 mg (tachyphylaxie)"],"unit_override":"mg bolus"}],"concentrations":[{"label":"Dilué 3 mg/mL","mg_per_ml":3},{"label":"30 mg/mL","mg_per_ml":30}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement nécessaire"]}'::jsonb,
 '["HTA sévère non contrôlée","Tachycardie sévère"]'::jsonb),

('noradrenaline',
 '{"fr":"Noradrénaline","pt":"Noradrenalina","en":"Norepinephrine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"vasopresseur","route":"IVSE","mg_per_kg":null,"max_mg":null,"notes":["Perfusion continue : 0.05-0.5 µg/kg/min","Voie veineuse centrale de préférence","Titrer selon PAM cible (≥ 65 mmHg)"],"unit_override":"µg/kg/min"}],"concentrations":[{"label":"Préparation IVSE variable","mg_per_ml":null}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement"]}'::jsonb,
 '["Pas de CI absolue en situation vitale"]'::jsonb),

('atropine',
 '{"fr":"Atropine","pt":"Atropina","en":"Atropine"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"bradycardie","route":"IV","mg_per_kg":0.01,"max_mg":0.5,"notes":["Dose minimale enfant : 0.1 mg (risque bradycardie paradoxale)","Répéter /3-5 min si nécessaire","Max total adulte : 3 mg"]}],"concentrations":[{"label":"0.25 mg/mL","mg_per_ml":0.25},{"label":"1 mg/mL","mg_per_ml":1}]}'::jsonb,
 '{"renal_hepatic_notes":["Pas d''ajustement"]}'::jsonb,
 '["Glaucome à angle fermé","Obstacle urétro-prostatique sévère"]'::jsonb),

('cefazoline',
 '{"fr":"Céfazoline","pt":"Cefazolina","en":"Cefazolin"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"antibioprophylaxie","route":"IV","mg_per_kg":25,"max_mg":2000,"notes":["30 min avant incision","Réinjection 1g si chirurgie > 4h","Alternative allergie : clindamycine 600 mg ou vancomycine"]}],"concentrations":[]}'::jsonb,
 '{"renal_hepatic_notes":["Ajuster intervalle si IRC sévère"]}'::jsonb,
 '["Allergie céphalosporines confirmée","Allergie pénicilline sévère (anaphylaxie)"]'::jsonb),

('acide_tranexamique',
 '{"fr":"Acide tranexamique","pt":"Ácido tranexâmico","en":"Tranexamic acid"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"antifibrinolytique","route":"IV lente","mg_per_kg":15,"max_mg":1000,"notes":["Injection lente 10-20 min (risque hypotension si rapide)","Réduit pertes sanguines péri-opératoires","Répétition possible à 3h si chirurgie prolongée"]}],"concentrations":[{"label":"100 mg/mL","mg_per_ml":100}]}'::jsonb,
 '{"renal_hepatic_notes":["Réduire dose si IRC (élimination rénale)"]}'::jsonb,
 '["Thrombose artérielle/veineuse active","Hématurie macro d''origine haute (risque caillotage urétéral)"]'::jsonb),

('enoxaparine',
 '{"fr":"Énoxaparine","pt":"Enoxaparina","en":"Enoxaparin"}'::jsonb,
 '{"dose_rules":[{"indication_tag":"thromboprophylaxie","route":"SC","mg_per_kg":null,"max_mg":null,"notes":["Dose prophylactique : 40 mg/j SC (standard)","Haut risque : 40 mg × 2/j SC","1ère injection : 6-12h après chirurgie","Contre-indiquée si SPA < 12h (rachianesthésie)"],"unit_override":"mg/j"},{"indication_tag":"thromboprophylaxie_curatif","route":"SC","mg_per_kg":1,"max_mg":null,"notes":["Dose curative : 1 mg/kg × 2/j SC","Adapter selon anti-Xa si IRC"]}],"concentrations":[{"label":"40 mg/0.4 mL","mg_per_ml":100},{"label":"60 mg/0.6 mL","mg_per_ml":100}]}'::jsonb,
 '{"renal_hepatic_notes":["DFG < 30 mL/min : réduire à 20 mg/j prophylactique","Surveillance anti-Xa si IRC"]}'::jsonb,
 '["Hémorragie active","Thrombopénie induite par héparine (TIH)","Prothèse valvulaire mécanique (CI relative)"]'::jsonb)

ON CONFLICT (id) DO NOTHING;

-- =============================================================
-- FIM — Schema AnesIA completo
-- ===-- ── 12. PROCEDURES ──────────────────────────────────────────

INSERT INTO public.procedures (id, specialty, titles, synonyms, content, tags, is_pro) VALUES
('pth', 'Orthopédie', '{"fr":"Prothèse totale de hanche (PTH)","pt":"Prótese total da anca (PTA)","en":"Total hip replacement (THR)"}'::jsonb, '{"fr":["PTH","arthroplastie hanche","prothèse hanche"],"en":["THR","hip arthroplasty"],"pt":["PTA","artroplastia anca"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation cardiovasculaire et capacité fonctionnelle","Bilan : NFS, coagulation, groupage sanguin + RAI","Jeûne 6h solides / 2h liquides clairs","Prévoir culots globulaires (risque hémorragique)","Prophylaxie thromboembolique pré-opératoire"],"intraop":["AG ou rachianesthésie (bupivacaïne hyperbare 10-12.5 mg)","Antibioprophylaxie : céfazoline 2g IV avant incision","Position décubitus latéral — vérifier points d''appui","Surveillance pertes sanguines (aspiration + compresses)","Acide tranexamique 1g IV si pas de CI","Maintien normothermie active"],"postop":["Analgésie multimodale : paracétamol + AINS ± morphine titration","Prévention NVPO : ondansétron ± dexaméthasone","Thromboprophylaxie HBPM dès H6","Mobilisation précoce J0-J1","Surveillance neurovasculaire du membre opéré"],"red_flags":["Syndrome du ciment : hypotension brutale + bradycardie à la cimentation","Choc hémorragique : surveiller hémodynamique et Hb","Fracture peropératoire du fémur","Embolie graisseuse (dyspnée, pétéchies, confusion)"],"drugs":[{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"acide_tranexamique","indication_tag":"antifibrinolytique"},{"drug_id":"morphine","indication_tag":"analgésie_postop"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["Population souvent âgée avec comorbidités cardiovasculaires fréquentes.","La rachianesthésie réduit les pertes sanguines et le risque thromboembolique vs AG.","L''acide tranexamique réduit significativement les besoins transfusionnels.","Le bloc du nerf fémoral ou IPACK peut compléter l''analgésie."],"pitfalls":["Ne pas sous-estimer les pertes sanguines cachées dans les tissus.","Le syndrome du ciment peut mimer un arrêt cardiaque — avoir éphédrine et adrénaline prêtes.","Attention au positionnement : lésions nerveuses par compression."],"references":[{"source":"ESA Guidelines — Hip Arthroplasty","year":2023,"note":"Recommandations péri-opératoires PTH"},{"source":"SFAR — Antibioprophylaxie en chirurgie","year":2018,"note":"Céfazoline 2g dose unique"}]}}}'::jsonb, '[]'::jsonb, false),
('turp', 'Urologie', '{"fr":"Résection transurétrale de prostate (TURP/RTUP)","pt":"Ressecção transuretral da próstata (RTUP)","en":"Transurethral resection of prostate (TURP)"}'::jsonb, '{"fr":["TURP","RTUP","résection prostate","adénomectomie endoscopique"],"en":["TURP","prostate resection"],"pt":["RTUP"]}'::jsonb, '{"quick":{"fr":{"preop":["Population âgée : évaluation cardiovasculaire approfondie","Bilan : NFS, ionogramme, créatinine, coagulation","Arrêt anticoagulants/antiagrégants selon recommandations","Groupage sanguin + RAI","Prévenir risque TURP syndrome (glycocolle)"],"intraop":["Rachianesthésie (niveau T10) préférentielle — permet détecter signes TURP syndrome","Surveillance ionogramme peropératoire si durée > 60 min","Monitoring température — irrigation froide","Limiter durée résection < 90 min si possible","Antibioprophylaxie selon protocole"],"postop":["Surveillance hématurie et irrigation vésicale","Ionogramme de contrôle (natrémie)","Analgésie : paracétamol ± antispasmodiques","Surveillance reprise mictionnelle après retrait sonde"],"red_flags":["TURP syndrome : hyponatrémie de dilution (confusion, nausées, convulsions, troubles visuels)","Hémorragie massive avec choc","Perforation vésicale (douleur abdominale, distension)"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ephedrine","indication_tag":"hypotension"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["La rachianesthésie est préférée : le patient conscient permet de détecter précocement les signes du TURP syndrome.","Le TURP syndrome est lié à l''absorption de glycocolle hypotonique — risque si durée > 60 min.","Les nouvelles techniques (laser, plasma) réduisent ce risque mais ne l''éliminent pas."],"pitfalls":["Une natrémie < 120 mmol/L est une urgence vitale — traitement par NaCl hypertonique.","Ne pas confondre agitation per-rachianesthésie avec inconfort simple — penser TURP syndrome."],"references":[{"source":"EAU Guidelines — BPH Management","year":2023,"note":"Recommandations techniques et anesthésiques"},{"source":"BJA Education — TURP syndrome","year":2019,"note":"Physiopathologie et prise en charge"}]}}}'::jsonb, '[]'::jsonb, false),
('ureteroscopie_dj', 'Urologie', '{"fr":"Urétéroscopie avec pose de sonde double J","pt":"Ureteroscopia com duplo J","en":"Ureteroscopy with double-J stent"}'::jsonb, '{"fr":["URS","double J","urétéroscopie","JJ"],"en":["URS","DJ stent","ureteral stent"],"pt":["ureteroscopia","duplo J"]}'::jsonb, '{"quick":{"fr":{"preop":["ECBU stérile obligatoire (< 48h)","Bilan rénal (créatinine, DFG)","Jeûne standard","Information sur douleur post-JJ (coliques, dysurie)"],"intraop":["AG courte ou rachianesthésie basse","Position gynécologique (lithotomie)","Antibioprophylaxie : céfazoline ou fluoroquinolone","Procédure courte (30-60 min habituel)"],"postop":["Analgésie : paracétamol + AINS","Surveillance diurèse et hématurie","Sortie ambulatoire J0 si stable","Consignes : consulter si fièvre, anurie, douleur intense"],"red_flags":["Perforation urétérale","Sepsis urinaire (fièvre, frissons post-procédure)","Colique néphrétique sur sonde JJ obstruée"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ibuprofene","indication_tag":"analgésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"}]}},"deep":{"fr":{"clinical":["Procédure ambulatoire fréquente, courte durée — anesthésie légère souvent suffisante.","La rachianesthésie offre une bonne relaxation urétérale.","AINS très efficaces sur la douleur post-JJ (composante spastique)."],"pitfalls":["Ne pas sous-estimer le risque infectieux si ECBU non vérifié.","La douleur post-sonde JJ est fréquente et peut nécessiter alpha-bloquants."],"references":[{"source":"EAU Guidelines — Urolithiasis","year":2023,"note":"Recommandations URS"},{"source":"SFAR — Ambulatoire urologique","year":2020,"note":"Critères sortie J0"}]}}}'::jsonb, '[]'::jsonb, false),
('cesarienne_urgente', 'Obstétrique', '{"fr":"Césarienne urgente","pt":"Cesariana urgente","en":"Emergency caesarean section"}'::jsonb, '{"fr":["césarienne","césarienne code rouge","c-section urgente"],"en":["emergency c-section","crash caesarean"],"pt":["cesariana emergência"]}'::jsonb, '{"quick":{"fr":{"preop":["ÉVALUATION URGENTE voies aériennes (Mallampati, ouverture buccale, CDD)","RAI + NFS en urgence — groupage sanguin si non fait","VVP gros calibre (16-18G) × 2 si possible","Position DLG (décubitus latéral gauche) jusqu''au bloc","Préoxygénation 3 min O2 pur ou 8 respirations capacité vitale","Antiacide : citrate de sodium 30 mL PO"],"intraop":["Rachianesthésie séquence rapide si délai > 5 min (bupivacaïne hyperbare 12 mg + sufentanil 2.5 µg IT)","Si code rouge / CI rachianesthésie : AG crash induction (propofol + rocuronium 1.2 mg/kg)","Cristalloïdes 500-1000 mL + éphédrine/phényléphrine prêts","Antibioprophylaxie : céfazoline 2g avant incision","Ocytocine 5 UI IV lente après extraction fœtale","Avoir sugammadex prêt si intubation difficile"],"postop":["Analgésie multimodale : paracétamol + AINS + morphine IT si rachianesthésie","Prévention NVPO : ondansétron","Surveillance hémorragie du post-partum (globe utérin, pertes)","Thromboprophylaxie","Favoriser peau-à-peau et allaitement précoce"],"red_flags":["Intubation difficile / impossible — algorithme can''t intubate can''t ventilate","Hémorragie du post-partum > 500 mL (> 1000 mL = sévère)","Éclampsie (convulsions → MgSO4)","Embolie amniotique (collapsus + CIVD)"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"sufentanil","indication_tag":"analgésie_IT"},{"drug_id":"propofol","indication_tag":"induction_AG"},{"drug_id":"rocuronium","indication_tag":"ISR"},{"drug_id":"sugammadex","indication_tag":"reversal_urgence"},{"drug_id":"ephedrine","indication_tag":"hypotension"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["La rachianesthésie est préférée même en urgence si le délai le permet (> 5 min) — meilleure sécurité maternelle.","L''AG expose au risque d''intubation difficile (modifications anatomiques grossesse) et d''inhalation.","Le rocuronium 1.2 mg/kg + sugammadex 16 mg/kg est l''alternative moderne à la succinylcholine en ISR.","L''hypotension post-rachianesthésie est quasi constante : prévention par co-remplissage + vasopresseurs."],"pitfalls":["Ne jamais retarder l''extraction pour « optimiser » l''anesthésie en code rouge.","Estomac toujours considéré plein : ISR obligatoire si AG.","L''ocytocine en bolus rapide peut causer hypotension sévère + tachycardie."],"references":[{"source":"SFAR/CARO — Césarienne","year":2023,"note":"Recommandations anesthésie obstétricale"},{"source":"NICE — Caesarean birth","year":2021,"note":"Classification urgence et prise en charge"}]}}}'::jsonb, '[]'::jsonb, false),
('cholecystectomie_lap', 'Chirurgie générale', '{"fr":"Cholécystectomie laparoscopique","pt":"Colecistectomia laparoscópica","en":"Laparoscopic cholecystectomy"}'::jsonb, '{"fr":["cholécystectomie","vésicule biliaire","cœlioscopie vésicule"],"en":["lap chole","gallbladder removal"],"pt":["colecistectomia","vesícula biliar"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan hépatique (transaminases, bilirubine, GGT, PAL)","Évaluation standard, jeûne","Évaluation risque PONV (score d''Apfel)","Prémédication si anxiété"],"intraop":["AG + intubation orotrachéale (IOT)","Infiltration trocarts bupivacaïne avant incision","Surveillance Pplateau (pneumopéritoine → ↑ pressions)","Prophylaxie NVPO multimodale (dexaméthasone + ondansétron)","Antibioprophylaxie si cholécystite aiguë"],"postop":["RAAC (récupération améliorée après chirurgie)","Analgésie multimodale : paracétamol + AINS + infiltration","Sortie J0-J1 si critères RAAC remplis","Alimentation précoce"],"red_flags":["Lésion des voies biliaires (ictère postopératoire, fuite biliaire)","Hémorragie sur artère cystique","Emphysème sous-cutané / pneumothorax (insufflation CO2)","Conversion en laparotomie"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"},{"drug_id":"dexamethasone","indication_tag":"PONV_anti-oedème"}]}},"deep":{"fr":{"clinical":["Chirurgie la plus fréquente en ambulatoire — excellente indication RAAC.","Le pneumopéritoine augmente les pressions d''insufflation et peut réduire le retour veineux.","Score d''Apfel élevé (femme, non-fumeuse, ATCD NVPO, morphine) → prophylaxie agressive."],"pitfalls":["Douleur scapulaire post-cœlioscopie fréquente (irritation phrénique) — prévenir le patient.","L''infiltration des trocarts AVANT incision est plus efficace qu''après."],"references":[{"source":"SFAR — RAAC en chirurgie digestive","year":2021,"note":"Protocole RAAC cholécystectomie"},{"source":"ESPA — Consensus PONV","year":2020,"note":"Prophylaxie multimodale"}]}}}'::jsonb, '[]'::jsonb, false),
('appendicectomie_urgente', 'Chirurgie générale', '{"fr":"Appendicectomie urgente","pt":"Apendicectomia urgente","en":"Emergency appendectomy"}'::jsonb, '{"fr":["appendicectomie","appendicite","appendice"],"en":["appendectomy","appendicitis surgery"],"pt":["apendicectomia"]}'::jsonb, '{"quick":{"fr":{"preop":["PATIENT NON À JEUN — estomac plein","Bilan inflammatoire (NFS, CRP)","Hydratation IV (compensation pertes + jeûne)","Évaluation douleur et analgésie pré-opératoire","Antibioprophylaxie ou antibiothérapie si péritonite"],"intraop":["ISR (induction séquence rapide) — estomac plein","AG + IOT obligatoire","Cœlioscopie (standard) — même surveillance pneumopéritoine","Antibioprophylaxie : céfazoline ± métronidazole si péritonite"],"postop":["Analgésie multimodale : paracétamol ± morphine titration","Reprise alimentaire précoce si pas de péritonite","Surveillance infectieuse (température, NFS)","Sortie J1-J2 selon évolution"],"red_flags":["Inhalation bronchique (estomac plein) — surtout à l''induction","Péritonite généralisée (sepsis sévère)","Abcès post-opératoire"],"drugs":[{"drug_id":"propofol","indication_tag":"induction_ISR"},{"drug_id":"rocuronium","indication_tag":"ISR"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"morphine","indication_tag":"analgésie_postop"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["L''ISR est obligatoire : tout patient en urgence abdominale est considéré estomac plein.","Le rocuronium 1.2 mg/kg est l''alternative à la succinylcholine pour l''ISR, réversible par sugammadex.","L''antibiothérapie est thérapeutique (et non prophylactique) si appendicite compliquée."],"pitfalls":["Ne pas retarder la chirurgie pour obtenir le jeûne — l''ISR sécurise l''induction.","Attention aux diagnostics différentiels chez la femme jeune (GEU, torsion ovarienne)."],"references":[{"source":"SFAR — Estomac plein et urgence","year":2019,"note":"ISR et gestion voies aériennes"},{"source":"WSES — Acute Appendicitis Guidelines","year":2020,"note":"Prise en charge chirurgicale et antibiothérapie"}]}}}'::jsonb, '[]'::jsonb, false),
('hernie_discale_lombaire', 'Neurochirurgie', '{"fr":"Hernie discale lombaire (discectomie)","pt":"Hérnia discal lombar (discectomia)","en":"Lumbar disc herniation (discectomy)"}'::jsonb, '{"fr":["hernie discale","discectomie","laminectomie","sciatique chirurgie"],"en":["lumbar discectomy","herniated disc surgery"],"pt":["hérnia discal","discectomia lombar"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation neurologique de référence (déficit sensitivo-moteur, ROT)","Bilan standard (NFS, coagulation)","Douleur chronique fréquente — évaluer consommation d''opioïdes","Prévenir le patient : position ventrale peropératoire"],"intraop":["AG + IOT obligatoire","Position ventrale (genupectorale ou cadre de Wilson)","Protection points d''appui : yeux, nerfs, abdomen libre","Antibioprophylaxie : céfazoline 2g IV","Kétamine sub-anesthésique si patient douloureux chronique","Maintien normothermie"],"postop":["Évaluation neurologique immédiate (comparaison pré-op)","Analgésie multimodale : paracétamol + AINS + kétamine perfusion si besoin","Mobilisation précoce avec kinésithérapie","Surveillance : nouveau déficit = urgence diagnostique"],"red_flags":["Syndrome de la queue de cheval post-op (rétention urinaire, anesthésie périnéale)","Hématome épidural compressif (déficit progressif → IRM urgente)","Complications positionnement : compression oculaire, lésions plexus brachial"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"sufentanil","indication_tag":"analgésie_perop"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketamine","indication_tag":"co-analgésie"},{"drug_id":"dexamethasone","indication_tag":"PONV_anti-oedème"}]}},"deep":{"fr":{"clinical":["La position ventrale modifie la mécanique ventilatoire : surveiller les pressions d''insufflation.","Les patients douloureux chroniques sous opioïdes nécessitent souvent une co-analgésie par kétamine.","La dexaméthasone a un double intérêt : anti-PONV et réduction de l''œdème radiculaire."],"pitfalls":["Toujours vérifier les yeux après retournement — pas de compression directe.","L''abdomen doit être libre en DV pour éviter engorgement veineux épidural et saignement.","Un déficit neurologique nouveau en post-op est une urgence chirurgicale (reprise)."],"references":[{"source":"SFAR — Positionnement en neurochirurgie","year":2021,"note":"Prévention lésions positionnelles"},{"source":"Spine Journal — Enhanced recovery disc surgery","year":2022,"note":"Protocoles RAAC rachis"}]}}}'::jsonb, '[]'::jsonb, false),
('arthroscopie_epaule', 'Orthopédie', '{"fr":"Arthroscopie de l''épaule","pt":"Artroscopia do ombro","en":"Shoulder arthroscopy"}'::jsonb, '{"fr":["arthroscopie épaule","coiffe rotateurs","bankart","acromioplastie"],"en":["shoulder scope","rotator cuff arthroscopy"],"pt":["artroscopia ombro"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard + coagulation si bloc nerveux prévu","Consentement éclairé pour bloc interscalénique (BIS)","Évaluation voies aériennes (positionnement beach-chair)","Information : paralysie phrénique transitoire post-BIS"],"intraop":["AG + IOT ± bloc interscalénique échoguidé","Position beach-chair ou décubitus latéral","Beach-chair : surveillance PA invasive recommandée (risque hypotension cérébrale)","BIS : bupivacaïne 0.375% (15-20 mL) ± lidocaïne adjuvant","Normothermie (irrigation arthroscopique froide)"],"postop":["Analgésie excellente via BIS (6-12h) + multimodale relais","Écharpe immobilisation","Surveillance neurologique membre supérieur","AINS pour relais antalgique après levée du bloc"],"red_flags":["Paralysie phrénique (BIS) : dyspnée chez insuffisant respiratoire → CI relative","Syndrome de Horner (myosis, ptosis) — transitoire","Hypotension cérébrale en beach-chair (AVC si PA non maintenue)","Pneumothorax post-BIS (rare, échoguidage réduit le risque)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"bupivacaine","indication_tag":"BIS"},{"drug_id":"lidocaine","indication_tag":"BIS_adjuvant"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"}]}},"deep":{"fr":{"clinical":["Le BIS est le gold standard analgésique pour la chirurgie de l''épaule.","En beach-chair, maintenir PAM ≥ 60 mmHg au niveau du cercle de Willis (ajuster pour hauteur).","L''échoguidage a réduit drastiquement les complications du BIS."],"pitfalls":["La paralysie phrénique est quasi constante avec le BIS classique — attention BPCO/obèse.","Ne pas oublier la conversion PA bras-cerveau en beach-chair (- 15-20 mmHg).","Le BIS supra-claviculaire a moins de paralysie phrénique mais couvre moins bien C5-C6."],"references":[{"source":"ASRA — Peripheral Nerve Blocks Guidelines","year":2023,"note":"BIS échoguidé technique et complications"},{"source":"SFAR — ALR membre supérieur","year":2019,"note":"Recommandations pratiques"}]}}}'::jsonb, '[]'::jsonb, false),
('hysteroscopie_ambulatoire', 'Gynécologie', '{"fr":"Hystéroscopie ambulatoire","pt":"Histeroscopia ambulatória","en":"Outpatient hysteroscopy"}'::jsonb, '{"fr":["hystéroscopie","résection hystéroscopique","polype utérin"],"en":["hysteroscopy","uterine polypectomy"],"pt":["histeroscopia"]}'::jsonb, '{"quick":{"fr":{"preop":["Test de grossesse (β-hCG) si femme en âge de procréer","Bilan standard minimal (ASA 1-2 souvent)","Jeûne standard","Information ambulatoire : sortie J0 avec accompagnant"],"intraop":["AG masque laryngé (procédure courte, pas d''intubation nécessaire)","Propofol AIVOC ou bolus + entretien sévoflurane","Position gynécologique (lithotomie)","Surveillance volume irrigation (glycine/sérum physiologique)","Prophylaxie NVPO si facteurs de risque"],"postop":["Sortie rapide (critères ambulatoires : Chung score ≥ 9)","Analgésie PO : paracétamol + ibuprofène","Surveillance saignement vaginal","Consignes de sortie avec numéro d''urgence"],"red_flags":["Perforation utérine (douleur, saignement, instabilité)","Surcharge liquidienne (absorption irrigation → hyponatrémie si glycine)","Réaction vagale (bradycardie, hypotension)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ibuprofene","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["Procédure ambulatoire par excellence — durée courte, récupération rapide.","Le masque laryngé est suffisant : pas de curarisation nécessaire.","Avec sérum physiologique (NaCl 0.9%), le risque d''hyponatrémie est éliminé vs glycine."],"pitfalls":["Toujours monitorer le bilan entrées/sorties de l''irrigation.","La réaction vagale est fréquente lors de la dilatation cervicale — atropine prête."],"references":[{"source":"RCOG — Best Practice in Outpatient Hysteroscopy","year":2019,"note":"Recommandations pratiques"},{"source":"SFAR — Ambulatoire gynécologique","year":2020,"note":"Critères de sortie"}]}}}'::jsonb, '[]'::jsonb, false),
('amygdalectomie_enfant', 'ORL', '{"fr":"Amygdalectomie chez l''enfant","pt":"Amigdalectomia na criança","en":"Pediatric tonsillectomy"}'::jsonb, '{"fr":["amygdalectomie","amygdales","adéno-amygdalectomie","tonsillectomie"],"en":["tonsillectomy","T&A","adenotonsillectomy"],"pt":["amigdalectomia","tonsilectomia"]}'::jsonb, '{"quick":{"fr":{"preop":["POIDS EXACT obligatoire (calcul doses pédiatriques)","Évaluation SAS/SAOS (polysomnographie si sévère → risque apnées post-op)","Bilan coagulation (TP, TCA ± PFA si ATCD hémorragique)","Jeûne adapté à l''âge (lait maternel 4h, lait artificiel 6h, solides 6h)","Crème anesthésiante (EMLA) sur sites ponction"],"intraop":["AG + IOT (tube RAE oral) — taille tube selon âge/poids","Induction inhalatoire (sévoflurane) ou IV si VVP en place","Dexaméthasone 0.15 mg/kg IV (anti-PONV + anti-œdème)","PAS de codéine chez l''enfant < 12 ans","Analgésie : paracétamol + ibuprofène (si > 6 mois)","Ondansétron 0.1 mg/kg pour PONV"],"postop":["Surveillance hémorragique 6h minimum en SSPI/UCA","Analgésie régulière (pas d''à-la-demande chez l''enfant)","Hydratation IV puis orale (liquides froids, glaces)","SAOS sévère : surveillance prolongée ≥ 24h (risque apnées post-op)","Morphine en secours si douleur non contrôlée (titration prudente)"],"red_flags":["Hémorragie post-amygdalectomie précoce (< 24h) ou tardive (J5-J10)","Laryngospasme à l''extubation (enfant +++)","Dépression respiratoire (opioïdes + SAOS)","NVPO sévères (déshydratation)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"sevoflurane","indication_tag":"entretien"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ibuprofene","indication_tag":"analgésie"},{"drug_id":"dexamethasone","indication_tag":"PONV_anti-oedème"},{"drug_id":"ondansetron","indication_tag":"PONV"},{"drug_id":"morphine","indication_tag":"analgésie_secours"}]}},"deep":{"fr":{"clinical":["L''amygdalectomie est l''une des chirurgies pédiatriques les plus fréquentes et à plus haut risque de PONV.","Les enfants SAOS sévères sont très sensibles aux opioïdes : réduire doses et surveiller.","La dexaméthasone réduit PONV et œdème — bénéfice démontré sans augmentation du risque hémorragique.","L''ibuprofène est sûr et efficace post-amygdalectomie (études récentes réfutent le sur-risque hémorragique)."],"pitfalls":["NE JAMAIS utiliser codéine < 12 ans (métaboliseurs ultra-rapides → dépression respiratoire fatale).","Le laryngospasme est plus fréquent si extubation en stade 2 d''anesthésie — extuber éveillé ou profond.","L''hémorragie tardive (J5-J10) est souvent plus grave que la précoce — information parentale cruciale."],"references":[{"source":"ADARPEF/SFAR — Amygdalectomie pédiatrique","year":2022,"note":"Recommandations anesthésie"},{"source":"Cochrane — NSAIDs post-tonsillectomy","year":2021,"note":"Méta-analyse sécurité ibuprofène"}]}}}'::jsonb, '[]'::jsonb, false),
('arthroscopie_genou', 'Orthopédie', '{"fr":"Arthroscopie du genou (méniscectomie/ligamentoplastie)","pt":"Artroscopia do joelho (meniscectomia/ligamentoplastia)","en":"Knee arthroscopy (meniscectomy/ACL reconstruction)"}'::jsonb, '{"fr":["arthroscopie genou","méniscectomie","ligamentoplastie","LCA"],"en":["knee scope","ACL repair","meniscus surgery"],"pt":["artroscopia joelho","meniscectomia","LCA"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard (NFS, coagulation)","Évaluation mobilité et douleur de base","Jeûne standard 6h/2h","Information sur rééducation post-op"],"intraop":["AG ou rachianesthésie selon durée prévue","Garrot pneumatique : surveillance temps (< 120 min)","Antibioprophylaxie : céfazoline 2g IV","Infiltration intra-articulaire en fin de procédure","Position décubitus dorsal, genou fléchi"],"postop":["Analgésie multimodale : paracétamol + AINS ± morphine titration","Cryothérapie locale","Prévention NVPO : ondansétron si FDR","Mobilisation précoce J0 (méniscectomie) ou attelle (ligamentoplastie)","Thromboprophylaxie si ligamentoplastie"],"red_flags":["Syndrome compartimental (douleur disproportionnée sous garrot)","Thrombose veineuse profonde","Hémarthrose post-op importante","Lésion neurovasculaire poplitée"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["La méniscectomie simple est ambulatoire ; la ligamentoplastie nécessite souvent une nuit.","Le bloc du nerf fémoral ou le bloc au canal des adducteurs améliore l''analgésie post-op.","Le garrot prolongé (> 90 min) augmente le risque de lésion nerveuse et de syndrome de reperfusion."],"pitfalls":["Ne pas sous-estimer la douleur post-ligamentoplastie — prévoir analgésie multimodale.","La levée du garrot peut provoquer hypotension et acidose métabolique transitoire."],"references":[{"source":"ESSKA — Knee Arthroscopy Guidelines","year":2022,"note":"Recommandations péri-opératoires"},{"source":"SFAR — Chirurgie ambulatoire orthopédique","year":2020,"note":"Critères de sortie"}]}}}'::jsonb, '[]'::jsonb, false),
('ptg', 'Orthopédie', '{"fr":"Prothèse totale de genou (PTG)","pt":"Prótese total do joelho (PTJ)","en":"Total knee replacement (TKR)"}'::jsonb, '{"fr":["PTG","prothèse genou","arthroplastie genou"],"en":["TKR","knee replacement","knee arthroplasty"],"pt":["PTJ","artroplastia joelho"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation cardiovasculaire (population âgée)","Bilan : NFS, coagulation, groupage + RAI","Prophylaxie thromboembolique pré-op","Optimisation Hb pré-op si anémie (fer IV)"],"intraop":["Rachianesthésie ± bloc du nerf fémoral/canal adducteurs","Garrot pneumatique (120 min max)","Antibioprophylaxie : céfazoline 2g IV","Acide tranexamique 1g IV","Maintien normothermie active"],"postop":["Analgésie multimodale : paracétamol + AINS + bloc nerveux continu si possible","Thromboprophylaxie HBPM ≥ 14 jours","Mobilisation précoce J0 (RAAC)","Cryothérapie + kinésithérapie active","Surveillance neurovasculaire distale"],"red_flags":["Syndrome compartimental","Fracture peropératoire (fémur/tibia)","Embolie graisseuse","Infection prothétique précoce (fièvre + douleur + écoulement)"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"acide_tranexamique","indication_tag":"antifibrinolytique"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"morphine","indication_tag":"analgésie_postop"}]}},"deep":{"fr":{"clinical":["La rachianesthésie + bloc adducteurs est le gold standard actuel pour la PTG.","L''acide tranexamique réduit pertes sanguines et transfusions de 30-50%.","Le protocole RAAC réduit durée de séjour à 2-3 jours vs 5-7 historiquement."],"pitfalls":["La levée du garrot cause hypotension + acidose — anticiper.","Le bloc fémoral moteur peut retarder la rééducation — préférer canal adducteurs."],"references":[{"source":"ERAS Society — TKR Guidelines","year":2022,"note":"Protocole RAAC genou"},{"source":"SFAR — Tranexamic acid perioperative","year":2021,"note":"Recommandations ATX"}]}}}'::jsonb, '[]'::jsonb, false),
('fracture_radius', 'Orthopédie', '{"fr":"Fixation fracture radius distal (ORIF)","pt":"Fixação fratura rádio distal (ORIF)","en":"Distal radius fracture fixation (ORIF)"}'::jsonb, '{"fr":["fracture poignet","ORIF radius","Pouteau-Colles"],"en":["wrist fracture","ORIF radius","Colles fracture"],"pt":["fratura punho","ORIF rádio"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard","Évaluation neurovasculaire distale (pouls radial, sensibilité)","Jeûne — souvent chirurgie différée","Antalgiques en attendant le bloc"],"intraop":["Bloc axillaire échoguidé ± sédation ou AG courte","Garrot brachial","Antibioprophylaxie si fracture ouverte","Fluoroscopie peropératoire (protection radioprotection)"],"postop":["Analgésie multimodale : paracétamol + AINS","Surélévation du membre","Surveillance neurovasculaire (syndrome du canal carpien aigu)","Sortie ambulatoire J0 si bloc axillaire"],"red_flags":["Syndrome compartimental de l''avant-bras","Lésion neurovasculaire (nerf médian)","Déplacement secondaire sous plâtre"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"bloc_axillaire"},{"drug_id":"lidocaine","indication_tag":"adjuvant_bloc"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ibuprofene","indication_tag":"analgésie"}]}},"deep":{"fr":{"clinical":["Le bloc axillaire offre une analgésie post-op prolongée et permet l''ambulatoire.","L''ORIF par plaque palmaire est la technique standard actuelle."],"pitfalls":["Syndrome du canal carpien aigu post-op : douleur disproportionnée + paresthésies = urgence.","Ne pas oublier le test de Allen avant cathéter artériel radial si nécessaire."],"references":[{"source":"BSSH — Distal Radius Fracture Guidelines","year":2021,"note":"Prise en charge chirurgicale"}]}}}'::jsonb, '[]'::jsonb, false),
('osteosynthese_cheville', 'Orthopédie', '{"fr":"Ostéosynthèse de cheville","pt":"Osteossíntese do tornozelo","en":"Ankle fracture fixation"}'::jsonb, '{"fr":["fracture cheville","fracture malléole","ostéosynthèse malléolaire"],"en":["ankle ORIF","malleolar fracture fixation"],"pt":["fratura tornozelo","osteossíntese maleolar"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard","Évaluation neurovasculaire pied (pouls pédieux, tibial post.)","Immobilisation provisoire + antalgiques","Groupage si fracture complexe"],"intraop":["Rachianesthésie ou bloc poplité + saphène ± sédation","Décubitus dorsal, garrot cuisse","Antibioprophylaxie : céfazoline 2g","Fluoroscopie de contrôle"],"postop":["Analgésie multimodale : paracétamol + AINS + relais bloc","Surélévation membre inférieur","Thromboprophylaxie HBPM","Non-appui 6 semaines (selon type)"],"red_flags":["Syndrome compartimental de la jambe","Souffrance cutanée sur fracture (phlyctènes)","Thrombose veineuse profonde"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"}]}},"deep":{"fr":{"clinical":["Le bloc poplité + saphène offre une excellente analgésie post-op avec épargne motrice proximale.","La rachianesthésie est l''alternative simple et fiable."],"pitfalls":["Les phlyctènes sur fracture bi-malléolaire peuvent retarder la chirurgie — ne pas forcer.","Le bloc poplité peut masquer un syndrome compartimental — surveillance clinique attentive."],"references":[{"source":"AO Foundation — Ankle Fracture Management","year":2022,"note":"Principes d''ostéosynthèse"}]}}}'::jsonb, '[]'::jsonb, false),
('laminectomie_lombaire', 'Neurochirurgie', '{"fr":"Laminectomie lombaire","pt":"Laminectomia lombar","en":"Lumbar laminectomy"}'::jsonb, '{"fr":["laminectomie","sténose lombaire","décompression lombaire"],"en":["lumbar decompression","spinal stenosis surgery"],"pt":["laminectomia","descompressão lombar"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation neurologique de base (périmètre de marche, déficits)","Bilan standard + coagulation","Évaluation comorbidités (population souvent âgée)","Position ventrale prévue — informer le patient"],"intraop":["AG + IOT","Position ventrale (Wilson frame ou Relton-Hall)","Protection yeux + points d''appui + abdomen libre","Antibioprophylaxie : céfazoline 2g","Surveillance pertes sanguines (multi-niveaux = plus hémorragique)"],"postop":["Évaluation neurologique post-op immédiate","Analgésie multimodale : paracétamol + AINS + kétamine faible dose","Mobilisation précoce J0-J1","Surveillance drain si posé"],"red_flags":["Hématome épidural compressif (déficit progressif = urgence IRM)","Syndrome de la queue de cheval","Complications positionnement (cécité, lésion plexus)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketamine","indication_tag":"co-analgésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"}]}},"deep":{"fr":{"clinical":["La laminectomie multi-niveaux est plus hémorragique et longue que la simple discectomie.","La kétamine sub-anesthésique améliore l''analgésie et réduit la consommation d''opioïdes."],"pitfalls":["Toujours vérifier les yeux après positionnement en DV — pas de compression.","Un déficit neurologique nouveau post-op est une urgence chirurgicale."],"references":[{"source":"NICE — Lumbar Spinal Stenosis","year":2022,"note":"Indications et technique"}]}}}'::jsonb, '[]'::jsonb, false),
('arthrodese_cervicale', 'Neurochirurgie', '{"fr":"Arthrodèse cervicale antérieure (ACDF)","pt":"Artrodese cervical anterior (ACDF)","en":"Anterior cervical discectomy and fusion (ACDF)"}'::jsonb, '{"fr":["ACDF","arthrodèse cervicale","discectomie cervicale"],"en":["ACDF","cervical fusion","anterior cervical surgery"],"pt":["ACDF","artrodese cervical"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation neurologique cervicale complète","Évaluation voies aériennes ++ (mobilité cervicale limitée)","Imagerie rachis cervical disponible au bloc","Bilan standard + coagulation"],"intraop":["AG + IOT prudente (fibroscopie si mobilité cervicale réduite)","Position décubitus dorsal, cou en extension modérée","Monitoring neurophysiologique (PES/PEM) selon indication","Antibioprophylaxie : céfazoline 2g","Attention compression œsophage par écarteur"],"postop":["Évaluation neurologique + voix (nerf récurrent)","Surveillance hématome cervical (dyspnée, dysphagie = urgence)","Analgésie : paracétamol + AINS, opioïdes en secours","Minerve selon chirurgien"],"red_flags":["Hématome cervical compressif (dyspnée aiguë → réintubation urgente)","Lésion nerf récurrent (dysphonie)","Dysphagie post-op (œdème ou lésion œsophagienne)","Déficit neurologique nouveau"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"dexamethasone","indication_tag":"anti-oedème"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"}]}},"deep":{"fr":{"clinical":["L''intubation peut être difficile si canal cervical étroit — éviter l''hyperextension.","Le monitoring neurophysiologique est recommandé pour les cas multi-niveaux.","La dexaméthasone réduit l''œdème post-op et facilite la déglutition."],"pitfalls":["L''hématome cervical est une urgence vitale : ouverture au lit si détresse respiratoire.","Toujours vérifier la voix en post-op (paralysie récurrentielle)."],"references":[{"source":"NASS — ACDF Clinical Guidelines","year":2022,"note":"Recommandations chirurgicales"}]}}}'::jsonb, '[]'::jsonb, false),
('rtu_bexiga', 'Urologie', '{"fr":"Résection transurétrale de vessie (RTUV)","pt":"Ressecção transuretral de bexiga (RTUV)","en":"Transurethral resection of bladder (TURBT)"}'::jsonb, '{"fr":["RTUV","résection vésicale","tumeur vessie"],"en":["TURBT","bladder resection"],"pt":["RTUV","ressecção vesical"]}'::jsonb, '{"quick":{"fr":{"preop":["ECBU stérile obligatoire","Bilan standard + coagulation","Arrêt anticoagulants selon recommandations","Information : hématurie post-op attendue"],"intraop":["Rachianesthésie (T10) préférentielle","Éviter fasciculations (stimulation nerf obturateur → perforation)","Surveillance volume irrigation","Antibioprophylaxie selon protocole"],"postop":["Irrigation vésicale continue si hématurie","Surveillance diurèse et coloration urines","Analgésie : paracétamol + antispasmodiques","Retrait sonde J1-J2"],"red_flags":["Perforation vésicale (douleur abdominale, distension)","Réflexe obturateur → perforation (curare si nécessaire)","Hémorragie massive","Hyponatrémie de dilution (si glycine)"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ephedrine","indication_tag":"hypotension"}]}},"deep":{"fr":{"clinical":["La rachianesthésie permet de détecter la douleur d''une perforation vésicale.","Le réflexe obturateur (adduction cuisse) peut perforer la vessie — curaresation parfois nécessaire."],"pitfalls":["Toujours surveiller le bilan liquidien (entrées/sorties irrigation).","Ne pas confondre ballonnement vésical simple avec perforation."],"references":[{"source":"EAU — Bladder Cancer Guidelines","year":2023,"note":"Recommandations RTUV"}]}}}'::jsonb, '[]'::jsonb, false),
('nephrostomie_dj', 'Urologie', '{"fr":"Néphrostomie percutanée / Double-J","pt":"Nefrostomia percutânea / Duplo-J","en":"Percutaneous nephrostomy / Double-J stent"}'::jsonb, '{"fr":["néphrostomie","double J","drainage rénal"],"en":["nephrostomy","DJ stent","renal drainage"],"pt":["nefrostomia","duplo J"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan rénal (créatinine, DFG)","ECBU + bilan infectieux si pyélonéphrite","Coagulation (procédure à risque hémorragique)","Antibiothérapie si contexte septique"],"intraop":["AG courte ou sédation + AL selon technique","Position DV ou DL pour néphrostomie percutanée","Guidage fluoroscopique/échographique","Antibioprophylaxie : céfazoline"],"postop":["Surveillance drain/néphrostomie (débit, aspect)","Analgésie : paracétamol + AINS","Surveillance diurèse et fonction rénale","Bilan infectieux de contrôle"],"red_flags":["Hémorragie rénale (hématurie massive, choc)","Sepsis (fièvre, frissons post-procédure)","Pneumothorax (ponction haute)","Lésion organes adjacents"],"drugs":[{"drug_id":"propofol","indication_tag":"sédation"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"}]}},"deep":{"fr":{"clinical":["La néphrostomie percutanée est souvent réalisée en urgence pour drainage d''un rein obstrué infecté.","Le DJ est posé par voie endoscopique et souvent sous AL/sédation."],"pitfalls":["Attention au risque de sepsis sévère lors du drainage d''un rein infecté — antibiothérapie AVANT.","Ponction haute (> 12e côte) : risque pneumothorax."],"references":[{"source":"EAU — Urolithiasis Guidelines","year":2023,"note":"Drainage urgence"}]}}}'::jsonb, '[]'::jsonb, false),
('cesarienne_elective', 'Obstétrique', '{"fr":"Césarienne élective (programmée)","pt":"Cesariana eletiva (programada)","en":"Elective caesarean section"}'::jsonb, '{"fr":["césarienne programmée","césarienne élective","c-section programmée"],"en":["elective c-section","planned caesarean"],"pt":["cesariana programada","cesariana eletiva"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan : NFS, groupage + RAI, coagulation","Jeûne 6h solides / 2h liquides clairs","Évaluation voies aériennes (modifications grossesse)","Antiacide : citrate de sodium 30 mL PO","VVP gros calibre (16-18G)"],"intraop":["Rachianesthésie : bupivacaïne hyperbare 10-12 mg + sufentanil 2.5 µg + morphine 100 µg IT","Co-remplissage cristalloïdes + phényléphrine IVSE","Antibioprophylaxie : céfazoline 2g avant incision","Ocytocine 5 UI IV lente après extraction","Normothermie (couverture chauffante)"],"postop":["Analgésie excellente via morphine IT (24-48h) + paracétamol + AINS","Prévention NVPO : ondansétron","Thromboprophylaxie HBPM","Peau-à-peau et allaitement précoce","Mobilisation précoce J0"],"red_flags":["Hémorragie du post-partum (> 500 mL)","Hypotension sévère post-rachianesthésie","Prurit intense (morphine IT)","Dépression respiratoire tardive (morphine IT — surveillance 24h)"],"drugs":[{"drug_id":"bupivacaine","indication_tag":"rachianesthésie"},{"drug_id":"sufentanil","indication_tag":"analgésie_IT"},{"drug_id":"morphine","indication_tag":"analgésie_IT"},{"drug_id":"cefazoline","indication_tag":"antibioprophylaxie"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["La morphine intrathécale offre une analgésie de 24-48h — gold standard pour la césarienne.","La phényléphrine en perfusion continue prévient mieux l''hypotension que les bolus d''éphédrine.","Le co-remplissage (500-1000 mL pendant la rachianesthésie) est plus efficace que le pré-remplissage."],"pitfalls":["Surveillance respiratoire 24h si morphine IT (dépression tardive possible).","Le prurit est fréquent avec morphine IT — traiter par nalbuphine si sévère."],"references":[{"source":"SFAR/CARO — Césarienne programmée","year":2023,"note":"Protocole anesthésique"},{"source":"NICE — Caesarean birth","year":2021,"note":"Recommandations"}]}}}'::jsonb, '[]'::jsonb, false),
('conisation_leep', 'Gynécologie', '{"fr":"Conisation / LEEP","pt":"Conização / LEEP","en":"Conization / LEEP"}'::jsonb, '{"fr":["conisation","LEEP","résection anse diathermique","CIN"],"en":["conization","LEEP","LLETZ","cervical excision"],"pt":["conização","LEEP","CAF"]}'::jsonb, '{"quick":{"fr":{"preop":["Test de grossesse si femme en âge de procréer","Bilan standard minimal","Jeûne standard","Information ambulatoire"],"intraop":["AG masque laryngé (procédure courte 15-30 min)","Position gynécologique","Pas de curarisation nécessaire","Prophylaxie NVPO si FDR (score Apfel)"],"postop":["Sortie ambulatoire J0","Analgésie PO : paracétamol ± ibuprofène","Surveillance saignement vaginal","Consignes : consulter si saignement abondant ou fièvre"],"red_flags":["Hémorragie cervicale (rare, tamponnement local)","Perforation utérine (exceptionnel)","Réaction vagale"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["Procédure courte et ambulatoire par excellence.","Le masque laryngé sans curarisation est suffisant."],"pitfalls":["La réaction vagale lors de la manipulation cervicale est fréquente — atropine prête.","Saignement post-op rare mais possible à J7-J10 (chute d''escarre)."],"references":[{"source":"CNGOF — Conisation","year":2020,"note":"Recommandations pratiques"}]}}}'::jsonb, '[]'::jsonb, false),
('hernie_inguinale', 'Chirurgie générale', '{"fr":"Hernie inguinale (laparoscopie/TEP)","pt":"Hérnia inguinal (laparoscopia/TEP)","en":"Inguinal hernia repair (laparoscopic/TEP)"}'::jsonb, '{"fr":["hernie inguinale","TEP","TAPP","cure de hernie"],"en":["inguinal hernia","TEP repair","TAPP","hernia surgery"],"pt":["hérnia inguinal","herniorrafia"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard","Évaluation risque PONV","Jeûne standard","Information ambulatoire (sortie J0)"],"intraop":["AG + IOT (curarisation pour espace pré-péritonéal)","Infiltration trocarts","Antibioprophylaxie si prothèse (céfazoline)","Pneumopéritoine (CO2) — surveillance Pplateau"],"postop":["Analgésie multimodale : paracétamol + AINS + infiltration","RAAC — sortie J0 si critères remplis","Reprise activité légère J1-J2","Éviter efforts lourds 4-6 semaines"],"red_flags":["Hématome inguino-scrotal","Lésion vésicale (TEP)","Rétention urinaire post-op","Douleur chronique post-hernioplastie (lésion nerveuse)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"}]}},"deep":{"fr":{"clinical":["La TEP nécessite une bonne curarisation pour l''espace pré-péritonéal.","Le TAP block peut compléter l''analgésie post-op."],"pitfalls":["La rétention urinaire est fréquente — vérifier miction avant sortie ambulatoire.","La douleur chronique post-hernioplastie touche 5-10% des patients."],"references":[{"source":"HerniaSurge — International Guidelines","year":2018,"note":"Recommandations hernie inguinale"}]}}}'::jsonb, '[]'::jsonb, false),
('thyroidectomie', 'Chirurgie générale', '{"fr":"Thyroïdectomie","pt":"Tiroidectomia","en":"Thyroidectomy"}'::jsonb, '{"fr":["thyroïdectomie","thyroïde","lobectomie thyroïdienne"],"en":["thyroidectomy","thyroid surgery"],"pt":["tiroidectomia","tiroide"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan thyroïdien (TSH, T3, T4) — euthyroïdie obligatoire","Laryngoscopie pré-op (mobilité cordes vocales)","Évaluation voies aériennes (goitre compressif ?)","Calcium + vitamine D de base","Bilan standard"],"intraop":["AG + IOT (tube standard ou armé)","Monitoring nerf récurrent (NIM) si disponible","Position hyperextension cervicale","Antibioprophylaxie non systématique","Hémostase méticuleuse"],"postop":["Surveillance voix/dysphonie (nerf récurrent)","Surveillance signes hypocalcémie (Chvostek, Trousseau) — calcémie H6+J1","Surveillance hématome cervical (dyspnée = urgence)","Analgésie : paracétamol ± AINS"],"red_flags":["Hématome cervical compressif (dyspnée → ouverture points au lit)","Hypocalcémie aiguë (tétanie, spasme laryngé)","Paralysie récurrentielle bilatérale (stridor → réintubation)","Crise thyréotoxique (tachycardie, hyperthermie)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"dexamethasone","indication_tag":"anti-oedème"}]}},"deep":{"fr":{"clinical":["Le monitoring du nerf récurrent (NIM) nécessite l''absence de curarisation résiduelle lors de la stimulation.","L''hypocalcémie est la complication la plus fréquente de la thyroïdectomie totale."],"pitfalls":["L''hématome cervical est une urgence vitale — kit d''ouverture de cervicotomie au chevet.","La curarisation interfère avec le NIM : donner rocuronium faible dose ou pas du tout si NIM utilisé."],"references":[{"source":"ATA — Thyroid Surgery Guidelines","year":2022,"note":"Recommandations peri-op"}]}}}'::jsonb, '[]'::jsonb, false),
('mastectomie', 'Chirurgie générale', '{"fr":"Mastectomie / tumorectomie","pt":"Mastectomia / tumorectomia","en":"Mastectomy / lumpectomy"}'::jsonb, '{"fr":["mastectomie","tumorectomie","chirurgie sein","cancer sein"],"en":["mastectomy","lumpectomy","breast surgery"],"pt":["mastectomia","tumorectomia","cirurgia mama"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard + coagulation","Évaluation psychologique (anxiété +++)","Repérage ganglion sentinelle si prévu","Information sur douleur chronique post-mastectomie"],"intraop":["AG + IOT ou masque laryngé","Bloc PECS I + II ou bloc serratus échoguidé","Position décubitus dorsal, bras en abduction","Antibioprophylaxie : céfazoline si prothèse immédiate","Prophylaxie NVPO multimodale"],"postop":["Analgésie via bloc régional + paracétamol + AINS","Surveillance drain et hématome","Prévention NVPO agressive (femme + opioïdes = haut risque)","Kinésithérapie épaule précoce"],"red_flags":["Hématome expansif (réintervention)","Lymphœdème (à long terme)","Douleur chronique post-mastectomie (SDPM)","Pneumothorax (bloc PECS — rare)"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"bupivacaine","indication_tag":"bloc_PECS"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ketorolac","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"},{"drug_id":"dexamethasone","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["Le bloc PECS II est le gold standard analgésique pour la chirurgie mammaire.","La douleur chronique post-mastectomie touche 20-50% des patientes — la prévenir par analgésie multimodale."],"pitfalls":["Patientes à très haut risque PONV (femme + non-fumeuse + ATCD PONV) — prophylaxie triple.","Le bloc PECS trop profond peut causer un pneumothorax — échoguidage obligatoire."],"references":[{"source":"ESRA — PECS Block Guidelines","year":2021,"note":"Technique et indications"}]}}}'::jsonb, '[]'::jsonb, false),
('septoplastie', 'ORL', '{"fr":"Septoplastie / rhinoplastie fonctionnelle","pt":"Septoplastia / rinoplastia funcional","en":"Septoplasty / functional rhinoplasty"}'::jsonb, '{"fr":["septoplastie","rhinoplastie","déviation cloison nasale"],"en":["septoplasty","rhinoplasty","nasal septum surgery"],"pt":["septoplastia","rinoplastia","desvio septo nasal"]}'::jsonb, '{"quick":{"fr":{"preop":["Bilan standard","Évaluation voies aériennes","Arrêt aspirine/AINS 7 jours avant","Jeûne standard"],"intraop":["AG + IOT (tube oral RAE préféré)","Méchage nasal vasoconstricteur (adrénaline + lidocaïne topique)","Position proclive 15-20° (réduction saignement)","Antibioprophylaxie non systématique","Extubation prudente (sang dans oropharynx)"],"postop":["Méchage nasal (retrait J1-J2)","Analgésie : paracétamol + AINS dès retrait mèches","Humidification nasale","Position tête surélevée"],"red_flags":["Hémorragie post-op (reprise méchage)","Hématome de cloison (obstruction bilatérale → drainage urgence)","Inhalation de sang à l''extubation"],"drugs":[{"drug_id":"propofol","indication_tag":"induction"},{"drug_id":"rocuronium","indication_tag":"intubation"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"paracetamol","indication_tag":"analgésie"},{"drug_id":"ondansetron","indication_tag":"PONV"}]}},"deep":{"fr":{"clinical":["L''extubation doit être prudente : aspiration oropharyngée systématique avant.","La position proclive réduit significativement le saignement peropératoire."],"pitfalls":["L''hématome de cloison est une urgence : risque de nécrose cartilagineuse si non drainé.","Ne pas oublier la protection oculaire (chirurgie faciale)."],"references":[{"source":"SFORL — Septoplastie","year":2020,"note":"Recommandations pratiques"}]}}}'::jsonb, '[]'::jsonb, false),
('microlaryngoscopie', 'ORL', '{"fr":"Microlaryngoscopie en suspension","pt":"Microlaringoscopia em suspensão","en":"Suspension microlaryngoscopy"}'::jsonb, '{"fr":["microlaryngoscopie","MLS","laryngoscopie directe","chirurgie laryngée"],"en":["microlaryngoscopy","MLS","direct laryngoscopy"],"pt":["microlaringoscopia","MLS"]}'::jsonb, '{"quick":{"fr":{"preop":["Évaluation voies aériennes ++ (stridor ? obstruction ?)","Scanner cervical si tumeur volumineuse","Bilan standard","Discussion plan airway avec chirurgien (tube petit calibre vs jet ventilation)"],"intraop":["AG TIVA (propofol + rémifentanil) — pas de sévoflurane (voies aériennes ouvertes)","IOT petit calibre (5.0-6.0) ou jet ventilation haute fréquence","Curarisation profonde (immobilité cordes vocales)","Protection oculaire + dentaire","FiO2 < 0.4 si laser (risque combustion)"],"postop":["Surveillance respiratoire étroite (œdème laryngé)","Dexaméthasone IV si œdème","Repos vocal","Position semi-assise","Surveillance saturation"],"red_flags":["Œdème laryngé post-op (stridor → adrénaline nébulisée ± réintubation)","Feu des voies aériennes (laser + O2 = combustion)","Fracture dentaire (laryngoscope en suspension)","Impossibilité de ventilation (tumeur obstructive)"],"drugs":[{"drug_id":"propofol","indication_tag":"TIVA"},{"drug_id":"rocuronium","indication_tag":"curarisation_profonde"},{"drug_id":"sugammadex","indication_tag":"reversal"},{"drug_id":"dexamethasone","indication_tag":"anti-oedème_laryngé"}]}},"deep":{"fr":{"clinical":["La TIVA est obligatoire si voies aériennes ouvertes (sévoflurane = pollution + risque explosion laser).","La jet ventilation permet un champ opératoire sans tube mais nécessite une expertise.","La curarisation profonde est essentielle pour l''immobilité des cordes vocales."],"pitfalls":["Le feu des voies aériennes avec le laser est une catastrophe — FiO2 < 0.4, tubes spéciaux laser.","Toujours avoir un plan de sauvetage airway (cricothyroïdotomie prête)."],"references":[{"source":"SFORL — Microlaryngoscopie","year":2021,"note":"Recommandations anesthésiques"}]}}}'::jsonb, '[]'::jsonb, false)
ON CONFLICT (id) DO UPDATE SET
  specialty = EXCLUDED.specialty,
  titles = EXCLUDED.titles,
  synonyms = EXCLUDED.synonyms,
  content = EXCLUDED.content,
  tags = EXCLUDED.tags,
  is_pro = EXCLUDED.is_pro,
  updated_at = now();

-- ── 13. GUIDELINES ──────────────────────────────────────────

INSERT INTO public.guidelines (id, category, titles, items, refs, tags) VALUES
('airway-management', 'airway', '{"fr":"Gestion des voies aériennes","en":"Airway management","pt":"Gestão da via aérea"}'::jsonb, '{"fr":["Évaluation systématique: Mallampati, ouverture buccale, distance thyro-mentonnière, mobilité cervicale","Prédicteurs d''intubation difficile: Mallampati III-IV, ouverture buccale < 3 cm, DTM < 6 cm","Plan A: laryngoscopie directe ou vidéo-laryngoscopie","Plan B: dispositif supra-glottique (masque laryngé)","Plan C: cricothyroïdotomie d''urgence (CICO)","Toujours vérifier capnographie après intubation","Chariot d''intubation difficile accessible dans chaque bloc"],"en":["Systematic assessment: Mallampati, mouth opening, thyromental distance, cervical mobility","Difficult intubation predictors: Mallampati III-IV, mouth opening < 3 cm, TMD < 6 cm","Plan A: direct or video laryngoscopy","Plan B: supraglottic airway device (laryngeal mask)","Plan C: emergency cricothyroidotomy (CICO)","Always verify capnography after intubation","Difficult airway cart accessible in every OR"],"pt":["Avaliação sistemática: Mallampati, abertura oral, distância tireo-mentoniana, mobilidade cervical","Preditores de intubação difícil: Mallampati III-IV, abertura oral < 3 cm, DTM < 6 cm","Plano A: laringoscopia direta ou videolaringoscopia","Plano B: dispositivo supraglótico (máscara laríngea)","Plano C: cricotiroidotomia de emergência (CICO)","Sempre verificar capnografia após intubação","Carro de via aérea difícil acessível em cada bloco"]}'::jsonb, '[{"source":"DAS Guidelines","year":2015},{"source":"ASA Practice Guidelines for Difficult Airway","year":2022}]'::jsonb, '[]'::jsonb),
('hemodynamic-monitoring', 'hemodynamics', '{"fr":"Monitorage hémodynamique","en":"Hemodynamic monitoring","pt":"Monitorização hemodinâmica"}'::jsonb, '{"fr":["Standard: ECG, PA non invasive, SpO2, capnographie","Invasif: PA invasive si chirurgie majeure, instabilité hémodynamique ou besoin de gazométrie fréquente","Voie veineuse centrale: chirurgie cardiaque, accès veineux limité, drogues vasopressives","Débit cardiaque: considérer pour chirurgie à haut risque (œsophage, hépatique, transplantation)","Objectif PAM ≥ 65 mmHg en peropératoire","Optimisation volémique guidée par le monitorage (goal-directed therapy)"],"en":["Standard: ECG, NIBP, SpO2, capnography","Invasive: arterial line if major surgery, hemodynamic instability, or frequent ABG needed","Central venous access: cardiac surgery, limited venous access, vasopressor infusions","Cardiac output: consider for high-risk surgery (esophageal, hepatic, transplant)","Target MAP ≥ 65 mmHg intraoperatively","Goal-directed fluid therapy with hemodynamic monitoring"],"pt":["Standard: ECG, PA não invasiva, SpO2, capnografia","Invasivo: PA invasiva se cirurgia major, instabilidade hemodinâmica ou necessidade de gasimetrias frequentes","Acesso venoso central: cirurgia cardíaca, acessos limitados, perfusões vasopressoras","Débito cardíaco: considerar para cirurgia de alto risco (esófago, hepática, transplante)","Objetivo PAM ≥ 65 mmHg intraoperatório","Otimização volémica guiada por monitorização (goal-directed therapy)"]}'::jsonb, '[{"source":"ESA Guidelines on Intraoperative Monitoring","year":2023},{"source":"ASA Standards for Basic Anesthetic Monitoring","year":2020}]'::jsonb, '[]'::jsonb),
('temperature-management', 'temperature', '{"fr":"Gestion de la température","en":"Temperature management","pt":"Gestão da temperatura"}'::jsonb, '{"fr":["Hypothermie peropératoire: T < 36°C — fréquente et sous-estimée","Conséquences: coagulopathie, infection du site opératoire, retard de réveil, frissons","Prévention: réchauffement actif par air pulsé (forced-air warming)","Monitorage continu: sonde œsophagienne, nasopharyngée ou vésicale","Réchauffer les solutés IV si perfusion > 500 mL/h","Objectif: maintenir T ≥ 36°C pendant toute l''intervention","Cas particulier: hypothermie thérapeutique en neurochirurgie (neuroprotection)"],"en":["Perioperative hypothermia: T < 36°C — common and underestimated","Consequences: coagulopathy, surgical site infection, delayed recovery, shivering","Prevention: forced-air warming blanket","Continuous monitoring: esophageal, nasopharyngeal or bladder probe","Warm IV fluids if infusion > 500 mL/h","Target: maintain T ≥ 36°C throughout surgery","Special case: therapeutic hypothermia in neurosurgery (neuroprotection)"],"pt":["Hipotermia perioperatória: T < 36°C — frequente e subestimada","Consequências: coagulopatia, infeção do local cirúrgico, despertar tardio, arrepios","Prevenção: aquecimento ativo por ar forçado (forced-air warming)","Monitorização contínua: sonda esofágica, nasofaríngea ou vesical","Aquecer soluções IV se perfusão > 500 mL/h","Objetivo: manter T ≥ 36°C durante toda a intervenção","Caso particular: hipotermia terapêutica em neurocirurgia (neuroproteção)"]}'::jsonb, '[{"source":"NICE CG65 - Inadvertent Perioperative Hypothermia","year":2016},{"source":"Sessler DI. Perioperative thermoregulation, NEJM","year":2018}]'::jsonb, '[]'::jsonb),
('pain-multimodal', 'pain', '{"fr":"Analgésie multimodale","en":"Multimodal analgesia","pt":"Analgesia multimodal"}'::jsonb, '{"fr":["Principe: combiner plusieurs classes analgésiques pour réduire les opioïdes","Palier 1: paracétamol 1g/6h IV ou PO (systématique si pas de contre-indication)","AINS: kétoprofène 100mg ou ibuprofène, sauf si risque rénal/hémorragique","Néfopam: 20mg IV lent (hors contre-indications: convulsions, glaucome)","ALR: infiltration locale, bloc nerveux périphérique, péridurale selon chirurgie","Kétamine sub-anesthésique: 0.15-0.3 mg/kg bolus, puis 0.1-0.2 mg/kg/h pour chirurgie douloureuse","Lidocaïne IV: 1-1.5 mg/kg bolus, puis 1-2 mg/kg/h (chirurgie abdominale)","Évaluation: EVA/EN systématique en SSPI, objectif EVA < 4"],"en":["Principle: combine multiple analgesic classes to reduce opioid consumption","Tier 1: acetaminophen 1g/6h IV or PO (routine if no contraindication)","NSAIDs: ketorolac 30mg or ibuprofen, unless renal/bleeding risk","Nefopam: 20mg slow IV (avoid if seizures, glaucoma)","Regional: local infiltration, peripheral nerve block, epidural as indicated","Sub-anesthetic ketamine: 0.15-0.3 mg/kg bolus, then 0.1-0.2 mg/kg/h for painful surgery","IV lidocaine: 1-1.5 mg/kg bolus, then 1-2 mg/kg/h (abdominal surgery)","Assessment: VAS/NRS systematic in PACU, target VAS < 4"],"pt":["Princípio: combinar várias classes analgésicas para reduzir opióides","Nível 1: paracetamol 1g/6h IV ou PO (sistemático se sem contra-indicação)","AINEs: cetorolaco 30mg ou ibuprofeno, exceto se risco renal/hemorrágico","Nefopam: 20mg IV lento (evitar se convulsões, glaucoma)","ALR: infiltração local, bloqueio nervoso periférico, peridural conforme cirurgia","Cetamina sub-anestésica: 0.15-0.3 mg/kg bólus, depois 0.1-0.2 mg/kg/h para cirurgia dolorosa","Lidocaína IV: 1-1.5 mg/kg bólus, depois 1-2 mg/kg/h (cirurgia abdominal)","Avaliação: EVA/EN sistemática na UCPA, objetivo EVA < 4"]}'::jsonb, '[{"source":"SFAR - RFE Analgésie postopératoire","year":2016},{"source":"PROSPECT Guidelines","year":2023}]'::jsonb, '[]'::jsonb),
('ponv-prevention', 'ponv', '{"fr":"Prévention des NVPO","en":"PONV prevention","pt":"Prevenção de NVPO"}'::jsonb, '{"fr":["Score d''Apfel: sexe féminin, non-fumeur, antécédent NVPO/mal des transports, opioïdes postop","Risque faible (0-1): pas de prophylaxie systématique","Risque modéré (2): monothérapie — dexaméthasone 4-8mg à l''induction OU ondansétron 4mg en fin d''intervention","Risque élevé (3-4): bithérapie — dexaméthasone + ondansétron ± dropéridol 0.625-1.25mg","TIVA propofol: réduit le risque de 30% vs halogénés","Minimiser les opioïdes: analgésie multimodale","Traitement curatif: utiliser une classe différente de la prophylaxie"],"en":["Apfel score: female sex, non-smoker, PONV/motion sickness history, postop opioids","Low risk (0-1): no routine prophylaxis","Moderate risk (2): monotherapy — dexamethasone 4-8mg at induction OR ondansetron 4mg at end of surgery","High risk (3-4): dual therapy — dexamethasone + ondansetron ± droperidol 0.625-1.25mg","TIVA propofol: reduces risk by 30% vs volatile agents","Minimize opioids: multimodal analgesia","Rescue treatment: use a different class from prophylaxis"],"pt":["Score de Apfel: sexo feminino, não fumador, antecedentes NVPO/cinetose, opióides pós-op","Risco baixo (0-1): sem profilaxia de rotina","Risco moderado (2): monoterapia — dexametasona 4-8mg na indução OU ondansetron 4mg no fim da cirurgia","Risco alto (3-4): terapia dupla — dexametasona + ondansetron ± droperidol 0.625-1.25mg","TIVA propofol: reduz risco em 30% vs halogenados","Minimizar opióides: analgesia multimodal","Tratamento de resgate: usar classe diferente da profilaxia"]}'::jsonb, '[{"source":"Consensus PONV (Gan et al.)","year":2020},{"source":"SFAR RFE NVPO","year":2022}]'::jsonb, '[]'::jsonb),
('fluid-management', 'fluid', '{"fr":"Remplissage vasculaire peropératoire","en":"Perioperative fluid management","pt":"Reposição volémica perioperatória"}'::jsonb, '{"fr":["Cristalloïdes balancés (Ringer Lactate) en première intention","Éviter NaCl 0.9% en grandes quantités (acidose hyperchlorémique)","Chirurgie mineure: 1-3 mL/kg/h de cristalloïdes","Chirurgie majeure: optimisation goal-directed (VPP, SVV, delta PP)","Colloïdes (HEA contre-indiqués en sepsis): gélatines ou albumine si hypoalbuminémie","Transfusion: seuil Hb < 7-8 g/dL (variable selon comorbidités cardiaques)","Objectif diurèse ≥ 0.5 mL/kg/h"],"en":["Balanced crystalloids (Ringer''s Lactate) as first-line","Avoid large volumes of NaCl 0.9% (hyperchloremic acidosis)","Minor surgery: 1-3 mL/kg/h crystalloids","Major surgery: goal-directed optimization (PPV, SVV, delta PP)","Colloids (HES contraindicated in sepsis): gelatins or albumin if hypoalbuminemia","Transfusion: threshold Hb < 7-8 g/dL (varies with cardiac comorbidities)","Target urine output ≥ 0.5 mL/kg/h"],"pt":["Cristalóides balanceados (Ringer Lactato) em primeira linha","Evitar NaCl 0.9% em grandes volumes (acidose hiperclorémica)","Cirurgia minor: 1-3 mL/kg/h de cristalóides","Cirurgia major: otimização goal-directed (VPP, SVV, delta PP)","Colóides (HEA contraindicados em sépsis): gelatinas ou albumina se hipoalbuminemia","Transfusão: limiar Hb < 7-8 g/dL (variável com comorbilidades cardíacas)","Objetivo diurese ≥ 0.5 mL/kg/h"]}'::jsonb, '[{"source":"SFAR RFE Remplissage vasculaire","year":2020},{"source":"Miller''s Anesthesia, Ch. Fluid Management","year":2020}]'::jsonb, '[]'::jsonb),
('preop-fasting', 'safety', '{"fr":"Jeûne préopératoire","en":"Preoperative fasting","pt":"Jejum pré-operatório"}'::jsonb, '{"fr":["Liquides clairs: 2h avant induction (eau, thé, café sans lait, jus sans pulpe)","Repas léger / lait maternel: 4h avant","Repas solide / lait non maternel: 6h avant","Repas riche en graisses: 8h avant","Chewing-gum: ne retarde PAS l''intervention","ERAS: boisson sucrée (maltodextrine) 2h avant si pas de diabète insulino-traité","Estomac plein: induction séquence rapide (ISR) avec Sellick"],"en":["Clear liquids: 2h before induction (water, tea, black coffee, pulp-free juice)","Light meal / breast milk: 4h before","Solid meal / formula: 6h before","High-fat meal: 8h before","Chewing gum: does NOT delay surgery","ERAS: carbohydrate drink (maltodextrin) 2h before if not insulin-treated diabetic","Full stomach: rapid sequence induction (RSI) with cricoid pressure"],"pt":["Líquidos claros: 2h antes da indução (água, chá, café sem leite, sumo sem polpa)","Refeição ligeira / leite materno: 4h antes","Refeição sólida / leite não materno: 6h antes","Refeição rica em gorduras: 8h antes","Pastilha elástica: NÃO atrasa a intervenção","ERAS: bebida açucarada (maltodextrina) 2h antes se não diabético insulino-tratado","Estômago cheio: indução de sequência rápida (ISR) com Sellick"]}'::jsonb, '[{"source":"ESA Preoperative Fasting Guidelines","year":2022},{"source":"ASA Practice Guidelines for Preoperative Fasting","year":2017}]'::jsonb, '[]'::jsonb),
('blood-products', 'hemodynamics', '{"fr":"Transfusion et produits sanguins","en":"Transfusion and blood products","pt":"Transfusão e produtos sanguíneos"}'::jsonb, '{"fr":["Seuil transfusionnel: Hb < 7 g/dL (patient sain), < 8-9 g/dL (coronarien, > 65 ans)","Toujours vérifier groupe sanguin, RAI, consentement","Contrôle ultime au lit du patient (CUSP) OBLIGATOIRE avant chaque transfusion","PFC: ratio PFC/CGR ≥ 1:2 en hémorragie massive, cible TP > 40%","Plaquettes: si < 50 000/mm³ avec saignement actif, < 100 000 en neurochirurgie","Fibrinogène: cible > 1.5-2 g/L, fibrinogène concentré 3g ou cryoprécipité","Acide tranexamique: 1g IV en 10 min dès hémorragie significative"],"en":["Transfusion threshold: Hb < 7 g/dL (healthy patient), < 8-9 g/dL (coronary disease, > 65y)","Always verify blood group, antibody screen, consent","Bedside compatibility check MANDATORY before each transfusion","FFP: ratio FFP/RBC ≥ 1:2 in massive hemorrhage, target PT > 40%","Platelets: if < 50,000/mm³ with active bleeding, < 100,000 in neurosurgery","Fibrinogen: target > 1.5-2 g/L, concentrated fibrinogen 3g or cryoprecipitate","Tranexamic acid: 1g IV over 10 min once significant hemorrhage"],"pt":["Limiar transfusional: Hb < 7 g/dL (doente saudável), < 8-9 g/dL (coronário, > 65 anos)","Sempre verificar grupo sanguíneo, pesquisa de anticorpos, consentimento","Controlo final à cabeceira OBRIGATÓRIO antes de cada transfusão","PFC: ratio PFC/CE ≥ 1:2 em hemorragia maciça, alvo TP > 40%","Plaquetas: se < 50.000/mm³ com hemorragia ativa, < 100.000 em neurocirurgia","Fibrinogénio: alvo > 1.5-2 g/L, fibrinogénio concentrado 3g ou crioprecipitado","Ácido tranexâmico: 1g IV em 10 min quando hemorragia significativa"]}'::jsonb, '[{"source":"SFAR RFE Transfusion","year":2019},{"source":"European Guidelines on Perioperative Bleeding Management","year":2023}]'::jsonb, '[]'::jsonb),
('neuromuscular-blockade', 'airway', '{"fr":"Curarisation et décurarisation","en":"Neuromuscular blockade and reversal","pt":"Curarização e descurarização"}'::jsonb, '{"fr":["Monitorage du TOF (Train-of-Four) obligatoire si curare utilisé","Intubation: succinylcholine 1 mg/kg (ISR) ou rocuronium 0.6-1.2 mg/kg","Entretien: rocuronium 0.1-0.2 mg/kg bolus ou cisatracurium perfusion","Décurarisation: TOF ratio ≥ 0.9 avant extubation","Néostigmine 40 µg/kg + atropine 20 µg/kg si TOF count ≥ 2","Sugammadex 2 mg/kg si TOF count ≥ 2, 4 mg/kg si PTC ≥ 1, 16 mg/kg si ISR","Curarisation résiduelle: risque majeur de complications respiratoires postop"],"en":["TOF (Train-of-Four) monitoring mandatory if NMB agent used","Intubation: succinylcholine 1 mg/kg (RSI) or rocuronium 0.6-1.2 mg/kg","Maintenance: rocuronium 0.1-0.2 mg/kg bolus or cisatracurium infusion","Reversal: TOF ratio ≥ 0.9 before extubation","Neostigmine 40 µg/kg + atropine 20 µg/kg if TOF count ≥ 2","Sugammadex 2 mg/kg if TOF count ≥ 2, 4 mg/kg if PTC ≥ 1, 16 mg/kg for RSI","Residual paralysis: major risk of postop respiratory complications"],"pt":["Monitorização do TOF (Train-of-Four) obrigatória se curare utilizado","Intubação: succinilcolina 1 mg/kg (ISR) ou rocurónio 0.6-1.2 mg/kg","Manutenção: rocurónio 0.1-0.2 mg/kg bólus ou cisatracúrio em perfusão","Descurarização: TOF ratio ≥ 0.9 antes da extubação","Neostigmina 40 µg/kg + atropina 20 µg/kg se TOF count ≥ 2","Sugamadex 2 mg/kg se TOF count ≥ 2, 4 mg/kg se PTC ≥ 1, 16 mg/kg se ISR","Curarização residual: risco major de complicações respiratórias pós-op"]}'::jsonb, '[{"source":"SFAR RFE Curares","year":2018},{"source":"European Guidelines on Neuromuscular Blockade","year":2023}]'::jsonb, '[]'::jsonb),
('antibiotic-prophylaxis', 'safety', '{"fr":"Antibioprophylaxie chirurgicale","en":"Surgical antibiotic prophylaxis","pt":"Antibioterapia profilática cirúrgica"}'::jsonb, '{"fr":["Administration: 30-60 min avant incision (idéalement à l''induction)","Céfazoline 2g IV (< 80 kg) ou 3g IV (≥ 80 kg) pour la majorité des chirurgies","Allergie pénicillines: clindamycine 600-900mg + gentamicine 5 mg/kg","Réinjection: céfazoline toutes les 4h si chirurgie prolongée, ou si pertes sanguines > 1500 mL","Durée: dose unique dans la majorité des cas, max 24h postop","Chirurgie cardiaque: céfazoline poursuivie 24-48h","Ne pas utiliser vancomycine en prophylaxie de routine"],"en":["Administration: 30-60 min before incision (ideally at induction)","Cefazolin 2g IV (< 80 kg) or 3g IV (≥ 80 kg) for most surgeries","Penicillin allergy: clindamycin 600-900mg + gentamicin 5 mg/kg","Redosing: cefazolin every 4h if prolonged surgery, or blood loss > 1500 mL","Duration: single dose in most cases, max 24h postop","Cardiac surgery: cefazolin continued 24-48h","Do not use vancomycin for routine prophylaxis"],"pt":["Administração: 30-60 min antes da incisão (idealmente na indução)","Cefazolina 2g IV (< 80 kg) ou 3g IV (≥ 80 kg) para a maioria das cirurgias","Alergia a penicilinas: clindamicina 600-900mg + gentamicina 5 mg/kg","Readministração: cefazolina a cada 4h se cirurgia prolongada ou perdas > 1500 mL","Duração: dose única na maioria dos casos, máximo 24h pós-op","Cirurgia cardíaca: cefazolina mantida 24-48h","Não usar vancomicina em profilaxia de rotina"]}'::jsonb, '[{"source":"SFAR RFE Antibioprophylaxie","year":2018},{"source":"WHO Surgical Site Infection Prevention","year":2018}]'::jsonb, '[]'::jsonb),
('thromboprophylaxis', 'safety', '{"fr":"Thromboprophylaxie périopératoire","en":"Perioperative thromboprophylaxis","pt":"Tromboprofilaxia perioperatória"}'::jsonb, '{"fr":["Évaluation du risque: score de Caprini ou score SFAR simplifié","Risque faible: mobilisation précoce, pas de prophylaxie médicamenteuse","Risque modéré à élevé: HBPM (énoxaparine 40 mg/j SC) débutée 6-12h postop","Risque très élevé: HBPM dose adaptée au poids + bas de contention","Chirurgie orthopédique majeure (PTH, PTG): 10-35 jours de prophylaxie","Chirurgie carcinologique abdominale: 28 jours de prophylaxie","Contre-indication HBPM: compression pneumatique intermittente"],"en":["Risk assessment: Caprini score or simplified risk stratification","Low risk: early mobilization, no pharmacological prophylaxis","Moderate to high risk: LMWH (enoxaparin 40 mg/day SC) starting 6-12h postop","Very high risk: weight-adjusted LMWH + compression stockings","Major orthopedic surgery (THR, TKR): 10-35 days of prophylaxis","Abdominal cancer surgery: 28 days of prophylaxis","LMWH contraindication: intermittent pneumatic compression"],"pt":["Avaliação do risco: score de Caprini ou estratificação simplificada","Risco baixo: mobilização precoce, sem profilaxia farmacológica","Risco moderado a alto: HBPM (enoxaparina 40 mg/dia SC) iniciada 6-12h pós-op","Risco muito alto: HBPM dose ajustada ao peso + meias de compressão","Cirurgia ortopédica major (PTA, PTJ): 10-35 dias de profilaxia","Cirurgia oncológica abdominal: 28 dias de profilaxia","Contra-indicação HBPM: compressão pneumática intermitente"]}'::jsonb, '[{"source":"SFAR RFE Thromboprophylaxie","year":2019},{"source":"ACCP Guidelines on Antithrombotic Therapy","year":2021}]'::jsonb, '[]'::jsonb),
('rapid-sequence-induction', 'airway', '{"fr":"Induction en séquence rapide (ISR)","en":"Rapid Sequence Induction (RSI)","pt":"Indução de sequência rápida (ISR)"}'::jsonb, '{"fr":["Indications: estomac plein, urgence, RGO sévère, occlusion, grossesse > 16 SA","Préoxygénation: 3-5 min FiO2 100% ou 8 respirations capacité vitale","Propofol 2-3 mg/kg ou kétamine 1.5-2 mg/kg (si instabilité hémodynamique)","Succinylcholine 1 mg/kg (délai 60s) OU rocuronium 1.2 mg/kg (délai 60-90s)","Pression cricoïde (Sellick): controversée mais encore pratiquée","Pas de ventilation au masque sauf désaturation < 95%","Matériel de recours immédiatement disponible: vidéolaryngoscope, ML, kit CICO"],"en":["Indications: full stomach, emergency, severe GERD, bowel obstruction, pregnancy > 16 weeks","Preoxygenation: 3-5 min FiO2 100% or 8 vital capacity breaths","Propofol 2-3 mg/kg or ketamine 1.5-2 mg/kg (if hemodynamic instability)","Succinylcholine 1 mg/kg (onset 60s) OR rocuronium 1.2 mg/kg (onset 60-90s)","Cricoid pressure (Sellick): controversial but still practiced","No mask ventilation unless SpO2 < 95%","Rescue equipment immediately available: videolaryngoscope, LMA, CICO kit"],"pt":["Indicações: estômago cheio, urgência, RGE grave, oclusão intestinal, gravidez > 16 sem","Pré-oxigenação: 3-5 min FiO2 100% ou 8 respirações de capacidade vital","Propofol 2-3 mg/kg ou cetamina 1.5-2 mg/kg (se instabilidade hemodinâmica)","Succinilcolina 1 mg/kg (início 60s) OU rocurónio 1.2 mg/kg (início 60-90s)","Pressão cricoide (Sellick): controversa mas ainda praticada","Sem ventilação por máscara exceto se SpO2 < 95%","Material de resgate imediatamente disponível: videolaringoscópio, ML, kit CICO"]}'::jsonb, '[{"source":"SFAR RFE ISR","year":2019},{"source":"DAS RSI Guidelines","year":2021}]'::jsonb, '[]'::jsonb)
ON CONFLICT (id) DO NOTHING;

-- ── 14. PROTOCOLES ──────────────────────────────────────────

INSERT INTO public.protocoles (id, category, titles, steps, refs, tags) VALUES
('who-surgical-safety', 'safety', '{"fr":"Checklist de sécurité chirurgicale OMS","en":"WHO Surgical Safety Checklist","pt":"Checklist de segurança cirúrgica OMS"}'::jsonb, '{"fr":["SIGN IN (avant induction): confirmer identité, site opératoire, intervention, consentement","Vérifier marquage du site chirurgical","Contrôle de sécurité de l''appareil d''anesthésie et médicaments","Oxymètre de pouls fonctionnel sur le patient","Allergie connue? Voie aérienne difficile? Risque hémorragique?","TIME OUT (avant incision): tous les membres se présentent","Confirmer patient, site, procédure","Antibioprophylaxie administrée dans les 60 dernières minutes?","Imagerie disponible? Événements critiques anticipés?","SIGN OUT (avant sortie de salle): nom de l''intervention enregistré","Comptage instruments, compresses, aiguilles — correct","Étiquetage prélèvements anatomopathologiques","Problèmes d''équipement à signaler?","Points clés pour la prise en charge postopératoire"],"en":["SIGN IN (before induction): confirm identity, site, procedure, consent","Verify surgical site marking","Anesthesia machine and medication safety check","Pulse oximeter on patient and functioning","Known allergy? Difficult airway? Bleeding risk?","TIME OUT (before incision): all team members introduce themselves","Confirm patient, site, procedure","Antibiotic prophylaxis given within last 60 minutes?","Imaging displayed? Critical events anticipated?","SIGN OUT (before leaving OR): procedure name recorded","Instrument, sponge, needle count — correct","Specimen labeling","Equipment problems to report?","Key concerns for postoperative care"],"pt":["SIGN IN (antes da indução): confirmar identidade, local, intervenção, consentimento","Verificar marcação do local cirúrgico","Controlo de segurança do aparelho de anestesia e medicamentos","Oxímetro de pulso no doente e a funcionar","Alergia conhecida? Via aérea difícil? Risco hemorrágico?","TIME OUT (antes da incisão): todos os membros se apresentam","Confirmar doente, local, procedimento","Antibioterapia profilática administrada nos últimos 60 minutos?","Imagiologia disponível? Eventos críticos antecipados?","SIGN OUT (antes de sair da sala): nome da intervenção registado","Contagem de instrumentos, compressas, agulhas — correta","Etiquetagem de amostras anatomopatológicas","Problemas de equipamento a reportar?","Pontos chave para cuidados pós-operatórios"]}'::jsonb, '[{"source":"WHO Surgical Safety Checklist","year":2009},{"source":"Haynes AB et al. NEJM","year":2009}]'::jsonb, '[]'::jsonb),
('ponv-protocol', 'ponv', '{"fr":"Protocole NVPO (nausées-vomissements postopératoires)","en":"PONV Protocol","pt":"Protocolo NVPO"}'::jsonb, '{"fr":["1. Évaluer le score d''Apfel en préopératoire","2. Risque faible (0-1 facteurs): pas de prophylaxie systématique","3. Risque modéré (2 facteurs): dexaméthasone 4-8mg IV à l''induction","4. Risque élevé (3-4 facteurs): bithérapie dexaméthasone 4-8mg + ondansétron 4mg fin de chirurgie","5. Considérer TIVA propofol si risque élevé","6. Analgésie multimodale pour réduire les opioïdes","7. Traitement de secours en SSPI: ondansétron 4mg IV si pas déjà reçu","8. Si prophylaxie déjà reçue: utiliser une AUTRE classe (dropéridol 0.625mg, métoclopramide 10mg)","9. Documentation systématique du score NVPO et traitement dans le dossier"],"en":["1. Assess Apfel score preoperatively","2. Low risk (0-1 factors): no routine prophylaxis","3. Moderate risk (2 factors): dexamethasone 4-8mg IV at induction","4. High risk (3-4 factors): dual therapy dexamethasone 4-8mg + ondansetron 4mg end of surgery","5. Consider TIVA propofol if high risk","6. Multimodal analgesia to reduce opioids","7. Rescue in PACU: ondansetron 4mg IV if not already given","8. If prophylaxis already given: use DIFFERENT class (droperidol 0.625mg, metoclopramide 10mg)","9. Systematic documentation of PONV score and treatment"],"pt":["1. Avaliar score de Apfel no pré-operatório","2. Risco baixo (0-1 fatores): sem profilaxia de rotina","3. Risco moderado (2 fatores): dexametasona 4-8mg IV na indução","4. Risco alto (3-4 fatores): terapia dupla dexametasona 4-8mg + ondansetron 4mg no fim da cirurgia","5. Considerar TIVA propofol se risco alto","6. Analgesia multimodal para reduzir opióides","7. Resgate na UCPA: ondansetron 4mg IV se ainda não administrado","8. Se profilaxia já feita: usar OUTRA classe (droperidol 0.625mg, metoclopramida 10mg)","9. Documentação sistemática do score NVPO e tratamento"]}'::jsonb, '[{"source":"Consensus Guidelines on PONV (Gan et al.)","year":2020}]'::jsonb, '[]'::jsonb),
('massive-hemorrhage', 'emergency', '{"fr":"Protocole d''hémorragie massive","en":"Massive Hemorrhage Protocol","pt":"Protocolo de hemorragia maciça"}'::jsonb, '{"fr":["1. ALERTER: activer le protocole de transfusion massive (PTM)","2. Remplissage: cristalloïdes balancés en urgence, puis sang O négatif si immédiat","3. Prélèvements urgents: NFS, coagulation, fibrinogène, ionogramme, gazométrie","4. Acide tranexamique 1g IV en 10 min dès le diagnostic","5. Ratio transfusionnel: CGR:PFC:Plaquettes = 1:1:1 ou 2:1:1","6. Objectifs: Hb > 7 g/dL, fibrinogène > 1.5 g/L, plaquettes > 50 000, TP > 40%","7. Fibrinogène concentré 3-4g si fibrinogène < 1.5 g/L","8. Calcium: maintenir Ca²⁺ ionisé > 1.0 mmol/L (citrate des PSL)","9. Réchauffer patient et produits sanguins","10. Réévaluer toutes les 30-60 min avec biologie de contrôle","11. Considérer chirurgie de damage control si coagulopathie réfractaire"],"en":["1. ALERT: activate massive transfusion protocol (MTP)","2. Resuscitation: balanced crystalloids, then O-negative blood if immediate need","3. Urgent labs: CBC, coagulation, fibrinogen, electrolytes, ABG","4. Tranexamic acid 1g IV over 10 min once diagnosed","5. Transfusion ratio: RBC:FFP:Platelets = 1:1:1 or 2:1:1","6. Targets: Hb > 7 g/dL, fibrinogen > 1.5 g/L, platelets > 50,000, PT > 40%","7. Concentrated fibrinogen 3-4g if fibrinogen < 1.5 g/L","8. Calcium: maintain Ca²⁺ ionized > 1.0 mmol/L (citrate from blood products)","9. Warm patient and blood products","10. Reassess every 30-60 min with repeat labs","11. Consider damage control surgery if refractory coagulopathy"],"pt":["1. ALERTAR: ativar protocolo de transfusão maciça (PTM)","2. Reposição: cristalóides balanceados em urgência, depois sangue O negativo se imediato","3. Análises urgentes: hemograma, coagulação, fibrinogénio, ionograma, gasimetria","4. Ácido tranexâmico 1g IV em 10 min ao diagnóstico","5. Ratio transfusional: CE:PFC:Plaquetas = 1:1:1 ou 2:1:1","6. Objetivos: Hb > 7 g/dL, fibrinogénio > 1.5 g/L, plaquetas > 50.000, TP > 40%","7. Fibrinogénio concentrado 3-4g se fibrinogénio < 1.5 g/L","8. Cálcio: manter Ca²⁺ ionizado > 1.0 mmol/L (citrato dos PSL)","9. Aquecer doente e produtos sanguíneos","10. Reavaliar a cada 30-60 min com biologia de controlo","11. Considerar cirurgia de damage control se coagulopatia refratária"]}'::jsonb, '[{"source":"European Guidelines on Perioperative Bleeding","year":2023},{"source":"SFAR RFE Hémorragie massive","year":2019}]'::jsonb, '[]'::jsonb),
('or-safety', 'safety', '{"fr":"Sécurité au bloc opératoire","en":"Operating Room Safety","pt":"Segurança no bloco operatório"}'::jsonb, '{"fr":["1. Vérifier l''appareil d''anesthésie au début de chaque journée (checklist constructeur)","2. Test d''étanchéité du circuit","3. Vérifier l''aspiration murale fonctionnelle","4. Chariot d''intubation difficile: vérifié et scellé","5. Chariot d''urgence: défibrillateur, médicaments d''urgence vérifiés","6. Vérifier les alarmes du monitorage (limites SpO2, PA, FC)","7. Identification des médicaments: étiquetage systématique (norme ISO)","8. Bracelet d''identification patient vérifié","9. Positionnement du patient: prévention des lésions nerveuses et escarres","10. Communication structurée (SBAR) entre équipes"],"en":["1. Check anesthesia machine at start of each day (manufacturer checklist)","2. Circuit leak test","3. Verify functional wall suction","4. Difficult airway cart: checked and sealed","5. Emergency cart: defibrillator, emergency drugs verified","6. Verify monitoring alarms (SpO2, BP, HR limits)","7. Drug identification: systematic labeling (ISO standard)","8. Patient ID bracelet verified","9. Patient positioning: prevention of nerve injury and pressure sores","10. Structured communication (SBAR) between teams"],"pt":["1. Verificar aparelho de anestesia no início de cada dia (checklist do fabricante)","2. Teste de estanquicidade do circuito","3. Verificar aspiração de parede funcional","4. Carro de via aérea difícil: verificado e selado","5. Carro de emergência: desfibrilhador, medicamentos de emergência verificados","6. Verificar alarmes da monitorização (limites SpO2, PA, FC)","7. Identificação de medicamentos: etiquetagem sistemática (norma ISO)","8. Pulseira de identificação do doente verificada","9. Posicionamento do doente: prevenção de lesões nervosas e escaras","10. Comunicação estruturada (SBAR) entre equipas"]}'::jsonb, '[{"source":"AAGBI Safety Guidelines","year":2020},{"source":"HAS Checklist Bloc Opératoire","year":2018}]'::jsonb, '[]'::jsonb),
('preop-fasting-protocol', 'preop', '{"fr":"Protocole de jeûne préopératoire","en":"Preoperative Fasting Protocol","pt":"Protocolo de jejum pré-operatório"}'::jsonb, '{"fr":["1. Liquides clairs (eau, thé, café noir, jus sans pulpe): autorisés jusqu''à 2h avant","2. Lait maternel: autorisé jusqu''à 4h avant","3. Repas léger: autorisé jusqu''à 6h avant l''intervention","4. Repas riche en graisses: 8h de jeûne minimum","5. Médicaments: pris avec une gorgée d''eau le matin (sauf indication contraire)","6. ERAS: boisson glucidique (maltodextrine 12.5%) 400 mL la veille + 200 mL 2h avant","7. Contre-indication ERAS: diabète insulino-traité, gastroparésie, RGO sévère","8. Si estomac plein: ISR obligatoire, documenter le risque"],"en":["1. Clear liquids (water, tea, black coffee, pulp-free juice): allowed up to 2h before","2. Breast milk: allowed up to 4h before","3. Light meal: allowed up to 6h before surgery","4. High-fat meal: minimum 8h fasting","5. Medications: taken with a sip of water in the morning (unless otherwise indicated)","6. ERAS: carbohydrate drink (maltodextrin 12.5%) 400 mL night before + 200 mL 2h before","7. ERAS contraindication: insulin-treated diabetes, gastroparesis, severe GERD","8. If full stomach: RSI mandatory, document the risk"],"pt":["1. Líquidos claros (água, chá, café sem leite, sumo sem polpa): permitidos até 2h antes","2. Leite materno: permitido até 4h antes","3. Refeição ligeira: permitida até 6h antes da intervenção","4. Refeição rica em gorduras: mínimo 8h de jejum","5. Medicamentos: tomar com gole de água de manhã (salvo indicação contrária)","6. ERAS: bebida glicídica (maltodextrina 12.5%) 400 mL na véspera + 200 mL 2h antes","7. Contra-indicação ERAS: diabetes insulino-tratada, gastroparésia, RGE grave","8. Se estômago cheio: ISR obrigatória, documentar o risco"]}'::jsonb, '[{"source":"ESA Preoperative Fasting Guidelines","year":2022}]'::jsonb, '[]'::jsonb),
('malignant-hyperthermia', 'emergency', '{"fr":"Hyperthermie maligne (protocole d''urgence)","en":"Malignant Hyperthermia (emergency protocol)","pt":"Hipertermia maligna (protocolo de emergência)"}'::jsonb, '{"fr":["1. SUSPECTER: rigidité musculaire, tachycardie, hypercapnie inexpliquée, hyperthermie rapide","2. ARRÊTER immédiatement tous les agents déclencheurs (halogénés, succinylcholine)","3. Hyperventiler à FiO2 100% avec débit de gaz frais ≥ 10 L/min","4. DANTROLÈNE 2.5 mg/kg IV bolus, répéter chaque 5 min jusqu''à régression (max ~10 mg/kg)","5. Refroidissement actif: solutés froids IV, glace axillaire/inguinale, lavage gastrique froid","6. Traiter hyperkaliémie: bicarbonate, glucose-insuline, calcium","7. Traiter arythmies (éviter bloqueurs calciques avec dantrolène)","8. Monitorage: gazométrie, K+, CK, myoglobine, diurèse horaire","9. Assurer diurèse > 2 mL/kg/h (prévention IRA myoglobinurique)","10. Transférer en réanimation pour surveillance ≥ 24-48h","11. Signaler au centre de référence et proposer diagnostic familial"],"en":["1. SUSPECT: muscle rigidity, tachycardia, unexplained hypercapnia, rapid hyperthermia","2. STOP immediately all triggering agents (volatiles, succinylcholine)","3. Hyperventilate at FiO2 100% with fresh gas flow ≥ 10 L/min","4. DANTROLENE 2.5 mg/kg IV bolus, repeat every 5 min until regression (max ~10 mg/kg)","5. Active cooling: cold IV fluids, axillary/inguinal ice, cold gastric lavage","6. Treat hyperkalemia: bicarbonate, glucose-insulin, calcium","7. Treat arrhythmias (avoid calcium channel blockers with dantrolene)","8. Monitoring: ABG, K+, CK, myoglobin, hourly urine output","9. Ensure urine output > 2 mL/kg/h (prevent myoglobinuric AKI)","10. Transfer to ICU for monitoring ≥ 24-48h","11. Report to reference center and offer family screening"],"pt":["1. SUSPEITAR: rigidez muscular, taquicardia, hipercapnia inexplicada, hipertermia rápida","2. PARAR imediatamente todos os agentes desencadeadores (halogenados, succinilcolina)","3. Hiperventilar a FiO2 100% com fluxo de gás fresco ≥ 10 L/min","4. DANTROLENO 2.5 mg/kg IV bólus, repetir a cada 5 min até regressão (máx ~10 mg/kg)","5. Arrefecimento ativo: soluções frias IV, gelo axilar/inguinal, lavagem gástrica fria","6. Tratar hipercaliemia: bicarbonato, glicose-insulina, cálcio","7. Tratar arritmias (evitar bloqueadores de cálcio com dantroleno)","8. Monitorização: gasimetria, K+, CK, mioglobina, diurese horária","9. Assegurar diurese > 2 mL/kg/h (prevenção IRA mioglobinúrica)","10. Transferir para UCI para vigilância ≥ 24-48h","11. Reportar ao centro de referência e propor diagnóstico familiar"]}'::jsonb, '[{"source":"MHAUS Guidelines","year":2023},{"source":"SFAR Protocole HM","year":2019}]'::jsonb, '[]'::jsonb),
('anaphylaxis', 'emergency', '{"fr":"Anaphylaxie peropératoire (protocole d''urgence)","en":"Perioperative Anaphylaxis (emergency protocol)","pt":"Anafilaxia perioperatória (protocolo de emergência)"}'::jsonb, '{"fr":["1. RECONNAÎTRE: hypotension brutale, bronchospasme, urticaire/érythème, tachycardie","2. ARRÊTER l''agent suspecté, appeler à l''aide","3. Adrénaline IV: Grade II 10-20 µg, Grade III 100-200 µg, Grade IV 1-2 mg","4. Remplissage rapide cristalloïdes 20-30 mL/kg","5. FiO2 100%, ventilation adaptée (bronchospasme: pression augmentée)","6. Trendelenburg si hypotension","7. Adrénaline en perfusion continue si instabilité persistante","8. Bronchospasme réfractaire: salbutamol IV ou nébulisé","9. Prélèvements: tryptase à T0, T1h, T24h + histamine si possible","10. Corticoïdes: méthylprednisolone 1-2 mg/kg (prévention réaction biphasique)","11. Surveillance ≥ 6-24h, bilan allergologique dans 4-6 semaines"],"en":["1. RECOGNIZE: sudden hypotension, bronchospasm, urticaria/erythema, tachycardia","2. STOP suspected agent, call for help","3. Epinephrine IV: Grade II 10-20 µg, Grade III 100-200 µg, Grade IV 1-2 mg","4. Rapid crystalloid bolus 20-30 mL/kg","5. FiO2 100%, adapted ventilation (bronchospasm: increased pressure)","6. Trendelenburg if hypotensive","7. Epinephrine infusion if persistent instability","8. Refractory bronchospasm: IV or nebulized salbutamol","9. Blood samples: tryptase at T0, T1h, T24h + histamine if possible","10. Corticosteroids: methylprednisolone 1-2 mg/kg (prevent biphasic reaction)","11. Monitoring ≥ 6-24h, allergy workup in 4-6 weeks"],"pt":["1. RECONHECER: hipotensão súbita, broncoespasmo, urticária/eritema, taquicardia","2. PARAR o agente suspeito, pedir ajuda","3. Adrenalina IV: Grau II 10-20 µg, Grau III 100-200 µg, Grau IV 1-2 mg","4. Reposição rápida cristalóides 20-30 mL/kg","5. FiO2 100%, ventilação adaptada (broncoespasmo: pressão aumentada)","6. Trendelenburg se hipotensão","7. Adrenalina em perfusão contínua se instabilidade persistente","8. Broncoespasmo refratário: salbutamol IV ou nebulizado","9. Colheitas: triptase a T0, T1h, T24h + histamina se possível","10. Corticóides: metilprednisolona 1-2 mg/kg (prevenção reação bifásica)","11. Vigilância ≥ 6-24h, estudo alergológico em 4-6 semanas"]}'::jsonb, '[{"source":"SFAR RFE Anaphylaxie périopératoire","year":2016},{"source":"NAP6 - Anaphylaxis in Anaesthesia","year":2018}]'::jsonb, '[]'::jsonb),
('antibioprophylaxis-protocol', 'preop', '{"fr":"Protocole d''antibioprophylaxie","en":"Antibiotic Prophylaxis Protocol","pt":"Protocolo de antibioterapia profilática"}'::jsonb, '{"fr":["1. Identifier le type de chirurgie (propre, propre-contaminée, contaminée)","2. Injection 30-60 minutes avant l''incision (idéalement à l''induction)","3. Chirurgie propre standard: céfazoline 2g IV (3g si ≥ 80 kg)","4. Chirurgie colorectale: céfazoline 2g + métronidazole 500mg","5. Chirurgie urologique: céfazoline 2g ou ciprofloxacine 400mg selon ECBU","6. Allergie pénicillines: clindamycine 600mg + gentamicine 5 mg/kg","7. Réinjection: céfazoline toutes les 4h si chirurgie > 4h ou pertes > 1500 mL","8. Durée maximale: dose unique (sauf exceptions: cardio, prothèse)","9. Documenter heure d''injection dans le dossier anesthésique"],"en":["1. Identify surgery type (clean, clean-contaminated, contaminated)","2. Inject 30-60 minutes before incision (ideally at induction)","3. Standard clean surgery: cefazolin 2g IV (3g if ≥ 80 kg)","4. Colorectal surgery: cefazolin 2g + metronidazole 500mg","5. Urologic surgery: cefazolin 2g or ciprofloxacin 400mg per urine culture","6. Penicillin allergy: clindamycin 600mg + gentamicin 5 mg/kg","7. Redosing: cefazolin every 4h if surgery > 4h or blood loss > 1500 mL","8. Maximum duration: single dose (exceptions: cardiac, prosthetic)","9. Document injection time in anesthetic record"],"pt":["1. Identificar tipo de cirurgia (limpa, limpa-contaminada, contaminada)","2. Injeção 30-60 minutos antes da incisão (idealmente na indução)","3. Cirurgia limpa standard: cefazolina 2g IV (3g se ≥ 80 kg)","4. Cirurgia colorretal: cefazolina 2g + metronidazol 500mg","5. Cirurgia urológica: cefazolina 2g ou ciprofloxacina 400mg conforme urocultura","6. Alergia a penicilinas: clindamicina 600mg + gentamicina 5 mg/kg","7. Readministração: cefazolina a cada 4h se cirurgia > 4h ou perdas > 1500 mL","8. Duração máxima: dose única (exceções: cardíaca, prótese)","9. Documentar hora da injeção no processo anestésico"]}'::jsonb, '[{"source":"SFAR RFE Antibioprophylaxie","year":2018}]'::jsonb, '[]'::jsonb),
('thromboprophylaxis-protocol', 'preop', '{"fr":"Protocole de thromboprophylaxie","en":"Thromboprophylaxis Protocol","pt":"Protocolo de tromboprofilaxia"}'::jsonb, '{"fr":["1. Évaluer le risque thromboembolique (score de Caprini ou SFAR)","2. Risque faible: mobilisation précoce seule","3. Risque modéré: HBPM (énoxaparine 40 mg/j SC) débutée 6-12h post-op","4. Risque élevé: HBPM dose adaptée + bas de contention classe 2","5. PTH/PTG: prophylaxie 10-14 jours (HBPM ou rivaroxaban)","6. Fracture col fémoral: prophylaxie 35 jours","7. Chirurgie carcinologique majeure: prophylaxie 28 jours","8. Contre-indications HBPM: compression pneumatique intermittente","9. Vérifier plaquettes si HBPM > 5 jours (risque TIH)","10. Documenter la stratégie dans le dossier"],"en":["1. Assess thromboembolic risk (Caprini score or similar)","2. Low risk: early mobilization only","3. Moderate risk: LMWH (enoxaparin 40 mg/day SC) starting 6-12h post-op","4. High risk: adjusted-dose LMWH + class 2 compression stockings","5. THR/TKR: prophylaxis 10-14 days (LMWH or rivaroxaban)","6. Hip fracture: prophylaxis 35 days","7. Major cancer surgery: prophylaxis 28 days","8. LMWH contraindications: intermittent pneumatic compression","9. Check platelets if LMWH > 5 days (HIT risk)","10. Document strategy in medical record"],"pt":["1. Avaliar risco tromboembólico (score de Caprini ou similar)","2. Risco baixo: mobilização precoce apenas","3. Risco moderado: HBPM (enoxaparina 40 mg/dia SC) iniciada 6-12h pós-op","4. Risco alto: HBPM dose ajustada + meias de compressão classe 2","5. PTA/PTJ: profilaxia 10-14 dias (HBPM ou rivaroxabano)","6. Fratura do colo do fémur: profilaxia 35 dias","7. Cirurgia oncológica major: profilaxia 28 dias","8. Contra-indicações HBPM: compressão pneumática intermitente","9. Verificar plaquetas se HBPM > 5 dias (risco TIH)","10. Documentar a estratégia no processo"]}'::jsonb, '[{"source":"SFAR RFE Thromboprophylaxie","year":2019},{"source":"ACCP Guidelines","year":2021}]'::jsonb, '[]'::jsonb),
('transfusion-protocol', 'emergency', '{"fr":"Protocole transfusionnel","en":"Transfusion Protocol","pt":"Protocolo transfusional"}'::jsonb, '{"fr":["1. Vérifier indication: Hb < 7 g/dL (sain), < 8-9 g/dL (coronarien/âgé)","2. Vérifier groupe sanguin + RAI (validité < 72h)","3. Commander produits sanguins labiles au dépôt","4. Contrôle ultime au lit du patient (CUSP): identité + concordance","5. Régler débit: 1 CGR en 30-60 min (sauf urgence vitale)","6. Surveiller les 15 premières minutes (réaction hémolytique immédiate)","7. Monitorage: température, PA, FC, signes de réaction transfusionnelle","8. En cas de réaction: ARRÊTER la transfusion, prélever hémocultures + bilan hémolytique","9. Documentation: traçabilité dans le dossier (numéro PSL, heure début/fin)","10. NFS de contrôle 1h après la fin de la transfusion"],"en":["1. Verify indication: Hb < 7 g/dL (healthy), < 8-9 g/dL (coronary disease/elderly)","2. Verify blood group + antibody screen (valid < 72h)","3. Order blood products from blood bank","4. Bedside compatibility check: identity + crossmatch verification","5. Set rate: 1 RBC unit in 30-60 min (unless life-threatening)","6. Monitor first 15 minutes (immediate hemolytic reaction)","7. Monitoring: temperature, BP, HR, signs of transfusion reaction","8. If reaction: STOP transfusion, blood cultures + hemolysis workup","9. Documentation: traceability in record (product number, start/end time)","10. CBC control 1h after transfusion completion"],"pt":["1. Verificar indicação: Hb < 7 g/dL (saudável), < 8-9 g/dL (coronário/idoso)","2. Verificar grupo sanguíneo + pesquisa de anticorpos (validade < 72h)","3. Requisitar produtos sanguíneos ao serviço de sangue","4. Controlo final à cabeceira: identidade + concordância","5. Regular débito: 1 CE em 30-60 min (salvo urgência vital)","6. Vigiar os primeiros 15 minutos (reação hemolítica imediata)","7. Monitorização: temperatura, PA, FC, sinais de reação transfusional","8. Em caso de reação: PARAR transfusão, hemoculturas + estudo hemolítico","9. Documentação: rastreabilidade no processo (número PSL, hora início/fim)","10. Hemograma de controlo 1h após o fim da transfusão"]}'::jsonb, '[{"source":"SFAR RFE Transfusion","year":2019}]'::jsonb, '[]'::jsonb)
ON CONFLICT (id) DO NOTHING;

-- ── 15. ALR BLOCKS ──────────────────────────────────────────

INSERT INTO public.alr_blocks (id, region, titles, indications, contraindications, technique, drugs, tags) VALUES
('interscalene', 'upper_limb', '{"fr":"Bloc interscalénique","en":"Interscalene block","pt":"Bloqueio interescalênico"}'::jsonb, '{"fr":["Chirurgie de l''épaule","Chirurgie de la clavicule","Humérus proximal"],"en":["Shoulder surgery","Clavicle surgery","Proximal humerus"],"pt":["Cirurgia do ombro","Cirurgia da clavícula","Úmero proximal"]}'::jsonb, '{"fr":["Paralysie phrénique controlatérale","Pneumonectomie controlatérale","BPCO sévère (relative)","Refus du patient"],"en":["Contralateral phrenic nerve palsy","Contralateral pneumonectomy","Severe COPD (relative)","Patient refusal"],"pt":["Paralisia frénica contralateral","Pneumonectomia contralateral","DPOC grave (relativa)","Recusa do doente"]}'::jsonb, '{"fr":["Repère échographique: racines C5-C6 entre scalène antérieur et moyen","Aiguille dans le plan, direction latérale vers médiale","Injection périneurale, hydrodissection","Volume: 15-20 mL","Attention: nerf phrénique ipsilatéral bloqué dans ~100% des cas"],"en":["Ultrasound landmark: C5-C6 roots between anterior and middle scalene","In-plane needle, lateral to medial approach","Perineural injection, hydrodissection","Volume: 15-20 mL","Note: ipsilateral phrenic nerve blocked in ~100% of cases"],"pt":["Referência ecográfica: raízes C5-C6 entre escaleno anterior e médio","Agulha no plano, direção lateral para medial","Injeção perineural, hidrodissecção","Volume: 15-20 mL","Atenção: nervo frénico ipsilateral bloqueado em ~100% dos casos"]}'::jsonb, '{"fr":["Ropivacaïne 0.375-0.5% (15-20 mL)","OU Lévobupivacaïne 0.25-0.5% (15-20 mL)","Adjuvant optionnel: dexaméthasone 4mg périneurale"],"en":["Ropivacaine 0.375-0.5% (15-20 mL)","OR Levobupivacaine 0.25-0.5% (15-20 mL)","Optional adjuvant: dexamethasone 4mg perineural"],"pt":["Ropivacaína 0.375-0.5% (15-20 mL)","OU Levobupivacaína 0.25-0.5% (15-20 mL)","Adjuvante opcional: dexametasona 4mg perineural"]}'::jsonb, '[]'::jsonb),
('supraclavicular', 'upper_limb', '{"fr":"Bloc supraclaviculaire","en":"Supraclavicular block","pt":"Bloqueio supraclavicular"}'::jsonb, '{"fr":["Chirurgie du coude","Chirurgie de l''avant-bras","Chirurgie de la main","Anesthésie du membre supérieur sous l''épaule"],"en":["Elbow surgery","Forearm surgery","Hand surgery","Upper limb anesthesia below shoulder"],"pt":["Cirurgia do cotovelo","Cirurgia do antebraço","Cirurgia da mão","Anestesia do membro superior abaixo do ombro"]}'::jsonb, '{"fr":["Pneumothorax controlatéral","Insuffisance respiratoire sévère","Coagulopathie"],"en":["Contralateral pneumothorax","Severe respiratory failure","Coagulopathy"],"pt":["Pneumotórax contralateral","Insuficiência respiratória grave","Coagulopatia"]}'::jsonb, '{"fr":["Repère: plexus brachial au-dessus de la clavicule, latéral à l''artère sous-clavière","Sonde linéaire haute fréquence","Aiguille dans le plan, direction latérale vers médiale","Volume: 20-25 mL","Risque de pneumothorax: rester superficiel, ne pas dépasser la 1ère côte"],"en":["Landmark: brachial plexus above clavicle, lateral to subclavian artery","High-frequency linear probe","In-plane needle, lateral to medial","Volume: 20-25 mL","Pneumothorax risk: stay superficial, do not pass first rib"],"pt":["Referência: plexo braquial acima da clavícula, lateral à artéria subclávia","Sonda linear de alta frequência","Agulha no plano, direção lateral para medial","Volume: 20-25 mL","Risco de pneumotórax: manter superficial, não ultrapassar a 1ª costela"]}'::jsonb, '{"fr":["Ropivacaïne 0.5% (20-25 mL)","OU Lévobupivacaïne 0.375% (20-25 mL)"],"en":["Ropivacaine 0.5% (20-25 mL)","OR Levobupivacaine 0.375% (20-25 mL)"],"pt":["Ropivacaína 0.5% (20-25 mL)","OU Levobupivacaína 0.375% (20-25 mL)"]}'::jsonb, '[]'::jsonb),
('axillary', 'upper_limb', '{"fr":"Bloc axillaire","en":"Axillary block","pt":"Bloqueio axilar"}'::jsonb, '{"fr":["Chirurgie du coude, avant-bras et main","Chirurgie de la fistule artério-veineuse","Bloc le plus sûr du membre supérieur"],"en":["Elbow, forearm and hand surgery","Arteriovenous fistula surgery","Safest upper limb block"],"pt":["Cirurgia do cotovelo, antebraço e mão","Cirurgia de fístula artério-venosa","Bloqueio mais seguro do membro superior"]}'::jsonb, '{"fr":["Infection au site de ponction","Lymphœdème du membre"],"en":["Infection at puncture site","Limb lymphedema"],"pt":["Infeção no local de punção","Linfedema do membro"]}'::jsonb, '{"fr":["Bras en abduction 90°, coude fléchi","Repère: artère axillaire, nerfs médian/ulnaire/radial/musculocutané","Injection périneurale de chaque nerf cible","Volume: 5-7 mL par nerf (total 20-30 mL)","Ne pas oublier le musculocutané (dans le coracobrachial)"],"en":["Arm abducted 90°, elbow flexed","Landmark: axillary artery, median/ulnar/radial/musculocutaneous nerves","Perineural injection of each target nerve","Volume: 5-7 mL per nerve (total 20-30 mL)","Don''t forget musculocutaneous (in coracobrachialis)"],"pt":["Braço em abdução 90°, cotovelo fletido","Referência: artéria axilar, nervos mediano/ulnar/radial/musculocutâneo","Injeção perineural de cada nervo alvo","Volume: 5-7 mL por nervo (total 20-30 mL)","Não esquecer o musculocutâneo (no coracobraquial)"]}'::jsonb, '{"fr":["Lidocaïne 1.5% + adrénaline (chirurgie courte)","OU Ropivacaïne 0.375-0.5% (chirurgie longue)","Mépivacaïne 1.5% (durée intermédiaire)"],"en":["Lidocaine 1.5% + epinephrine (short surgery)","OR Ropivacaine 0.375-0.5% (long surgery)","Mepivacaine 1.5% (intermediate duration)"],"pt":["Lidocaína 1.5% + adrenalina (cirurgia curta)","OU Ropivacaína 0.375-0.5% (cirurgia longa)","Mepivacaína 1.5% (duração intermédia)"]}'::jsonb, '[]'::jsonb),
('femoral', 'lower_limb', '{"fr":"Bloc fémoral","en":"Femoral nerve block","pt":"Bloqueio femoral"}'::jsonb, '{"fr":["Chirurgie du genou (LCA, PTG)","Fracture du fémur (analgésie)","Chirurgie de la cuisse antérieure"],"en":["Knee surgery (ACL, TKR)","Femur fracture (analgesia)","Anterior thigh surgery"],"pt":["Cirurgia do joelho (LCA, PTJ)","Fratura do fémur (analgesia)","Cirurgia da coxa anterior"]}'::jsonb, '{"fr":["Infection inguinale","Chirurgie vasculaire fémorale récente","Neuropathie fémorale préexistante"],"en":["Inguinal infection","Recent femoral vascular surgery","Pre-existing femoral neuropathy"],"pt":["Infeção inguinal","Cirurgia vascular femoral recente","Neuropatia femoral pré-existente"]}'::jsonb, '{"fr":["Repère: nerf fémoral latéral à l''artère fémorale, sous le ligament inguinal","Sonde linéaire haute fréquence","Aiguille dans le plan","Volume: 15-20 mL","Attention: faiblesse du quadriceps (risque de chute postop)"],"en":["Landmark: femoral nerve lateral to femoral artery, below inguinal ligament","High-frequency linear probe","In-plane needle","Volume: 15-20 mL","Note: quadriceps weakness (postop fall risk)"],"pt":["Referência: nervo femoral lateral à artéria femoral, abaixo do ligamento inguinal","Sonda linear de alta frequência","Agulha no plano","Volume: 15-20 mL","Atenção: fraqueza do quadricípite (risco de queda pós-op)"]}'::jsonb, '{"fr":["Ropivacaïne 0.375% (15-20 mL)","OU Lévobupivacaïne 0.25% (15-20 mL)"],"en":["Ropivacaine 0.375% (15-20 mL)","OR Levobupivacaine 0.25% (15-20 mL)"],"pt":["Ropivacaína 0.375% (15-20 mL)","OU Levobupivacaína 0.25% (15-20 mL)"]}'::jsonb, '[]'::jsonb),
('sciatic', 'lower_limb', '{"fr":"Bloc sciatique (poplité)","en":"Sciatic (popliteal) block","pt":"Bloqueio ciático (poplíteo)"}'::jsonb, '{"fr":["Chirurgie du pied et de la cheville","Chirurgie du tendon d''Achille","Amputation du pied"],"en":["Foot and ankle surgery","Achilles tendon surgery","Foot amputation"],"pt":["Cirurgia do pé e tornozelo","Cirurgia do tendão de Aquiles","Amputação do pé"]}'::jsonb, '{"fr":["Neuropathie sciatique préexistante","Infection au site de ponction"],"en":["Pre-existing sciatic neuropathy","Infection at puncture site"],"pt":["Neuropatia ciática pré-existente","Infeção no local de punção"]}'::jsonb, '{"fr":["Abord poplité postérieur: patient en décubitus ventral ou latéral","Repère: bifurcation du nerf sciatique (tibial + péronier commun) en creux poplité","Injection 1-3 cm au-dessus de la bifurcation","Volume: 20-25 mL","Abord antérieur possible (patient en décubitus dorsal)"],"en":["Posterior popliteal approach: patient prone or lateral","Landmark: sciatic nerve bifurcation (tibial + common peroneal) in popliteal fossa","Inject 1-3 cm above bifurcation","Volume: 20-25 mL","Anterior approach possible (patient supine)"],"pt":["Abordagem poplítea posterior: doente em decúbito ventral ou lateral","Referência: bifurcação do nervo ciático (tibial + peroneal comum) na fossa poplítea","Injeção 1-3 cm acima da bifurcação","Volume: 20-25 mL","Abordagem anterior possível (doente em decúbito dorsal)"]}'::jsonb, '{"fr":["Ropivacaïne 0.5% (20-25 mL)","OU Lévobupivacaïne 0.375% (20-25 mL)"],"en":["Ropivacaine 0.5% (20-25 mL)","OR Levobupivacaine 0.375% (20-25 mL)"],"pt":["Ropivacaína 0.5% (20-25 mL)","OU Levobupivacaína 0.375% (20-25 mL)"]}'::jsonb, '[]'::jsonb),
('adductor-canal', 'lower_limb', '{"fr":"Bloc du canal des adducteurs","en":"Adductor canal block","pt":"Bloqueio do canal adutor"}'::jsonb, '{"fr":["PTG (alternative au bloc fémoral)","Chirurgie du genou (analgésie avec préservation motrice)","Arthroscopie du genou"],"en":["TKR (alternative to femoral block)","Knee surgery (analgesia with motor sparing)","Knee arthroscopy"],"pt":["PTJ (alternativa ao bloqueio femoral)","Cirurgia do joelho (analgesia com preservação motora)","Artroscopia do joelho"]}'::jsonb, '{"fr":["Infection au site de ponction","Coagulopathie sévère"],"en":["Infection at puncture site","Severe coagulopathy"],"pt":["Infeção no local de punção","Coagulopatia grave"]}'::jsonb, '{"fr":["Repère: artère fémorale superficielle sous le sartorius, mi-cuisse","Sonde linéaire, coupe axiale","Injection profonde au sartorius, latérale à l''artère","Volume: 15-20 mL","Avantage: préservation de la force du quadriceps vs bloc fémoral"],"en":["Landmark: superficial femoral artery under sartorius, mid-thigh","Linear probe, axial view","Injection deep to sartorius, lateral to artery","Volume: 15-20 mL","Advantage: quadriceps strength preserved vs femoral block"],"pt":["Referência: artéria femoral superficial sob o sartório, a meio da coxa","Sonda linear, corte axial","Injeção profunda ao sartório, lateral à artéria","Volume: 15-20 mL","Vantagem: preservação da força do quadricípite vs bloqueio femoral"]}'::jsonb, '{"fr":["Ropivacaïne 0.25-0.375% (15-20 mL)","Adjuvant: dexaméthasone 4mg périneurale (optionnel)"],"en":["Ropivacaine 0.25-0.375% (15-20 mL)","Adjuvant: dexamethasone 4mg perineural (optional)"],"pt":["Ropivacaína 0.25-0.375% (15-20 mL)","Adjuvante: dexametasona 4mg perineural (opcional)"]}'::jsonb, '[]'::jsonb),
('tap-block', 'trunk', '{"fr":"TAP block (Transversus Abdominis Plane)","en":"TAP block (Transversus Abdominis Plane)","pt":"TAP block (Plano do Transverso Abdominal)"}'::jsonb, '{"fr":["Chirurgie abdominale (appendicectomie, cholécystectomie, césarienne)","Hernie inguinale","Analgésie pariétale abdominale"],"en":["Abdominal surgery (appendectomy, cholecystectomy, cesarean)","Inguinal hernia","Abdominal wall analgesia"],"pt":["Cirurgia abdominal (apendicectomia, colecistectomia, cesariana)","Hérnia inguinal","Analgesia parietal abdominal"]}'::jsonb, '{"fr":["Infection au site de ponction","Allergie aux anesthésiques locaux"],"en":["Infection at puncture site","Local anesthetic allergy"],"pt":["Infeção no local de punção","Alergia a anestésicos locais"]}'::jsonb, '{"fr":["Repère: triangle de Petit ou approche sous-costale","Sonde linéaire, entre crête iliaque et rebord costal","Injection entre oblique interne et transverse de l''abdomen","Volume: 20 mL par côté (bilatéral = 40 mL total)","Attention aux doses maximales d''AL en bilatéral"],"en":["Landmark: Petit triangle or subcostal approach","Linear probe, between iliac crest and costal margin","Injection between internal oblique and transversus abdominis","Volume: 20 mL per side (bilateral = 40 mL total)","Mind maximum LA doses in bilateral blocks"],"pt":["Referência: triângulo de Petit ou abordagem subcostal","Sonda linear, entre crista ilíaca e rebordo costal","Injeção entre oblíquo interno e transverso do abdómen","Volume: 20 mL por lado (bilateral = 40 mL total)","Atenção às doses máximas de AL em bilateral"]}'::jsonb, '{"fr":["Ropivacaïne 0.25-0.375% (20 mL/côté)","OU Bupivacaïne 0.25% (20 mL/côté)","Dose max ropivacaïne: 3 mg/kg"],"en":["Ropivacaine 0.25-0.375% (20 mL/side)","OR Bupivacaine 0.25% (20 mL/side)","Max dose ropivacaine: 3 mg/kg"],"pt":["Ropivacaína 0.25-0.375% (20 mL/lado)","OU Bupivacaína 0.25% (20 mL/lado)","Dose máx ropivacaína: 3 mg/kg"]}'::jsonb, '[]'::jsonb),
('paravertebral', 'trunk', '{"fr":"Bloc paravertébral","en":"Paravertebral block","pt":"Bloqueio paravertebral"}'::jsonb, '{"fr":["Chirurgie thoracique (thoracotomie, VATS)","Chirurgie du sein","Fractures de côtes (analgésie)","Alternative à la péridurale thoracique"],"en":["Thoracic surgery (thoracotomy, VATS)","Breast surgery","Rib fractures (analgesia)","Alternative to thoracic epidural"],"pt":["Cirurgia torácica (toracotomia, VATS)","Cirurgia da mama","Fraturas de costelas (analgesia)","Alternativa à peridural torácica"]}'::jsonb, '{"fr":["Infection au site de ponction","Tumeur paravertébrale","Coagulopathie sévère","Empyème"],"en":["Infection at puncture site","Paravertebral tumor","Severe coagulopathy","Empyema"],"pt":["Infeção no local de punção","Tumor paravertebral","Coagulopatia grave","Empiema"]}'::jsonb, '{"fr":["Repère: apophyse transverse, espace paravertébral","Échoguidage ou repères anatomiques","Aiguille perpendiculaire, contact transverse puis avance de 1-1.5 cm","Volume: 3-5 mL par niveau (multi-niveaux) ou 15-20 mL (injection unique)","Cathéter possible pour analgésie prolongée"],"en":["Landmark: transverse process, paravertebral space","Ultrasound-guided or anatomical landmarks","Perpendicular needle, contact transverse process then advance 1-1.5 cm","Volume: 3-5 mL per level (multi-level) or 15-20 mL (single injection)","Catheter possible for prolonged analgesia"],"pt":["Referência: apófise transversa, espaço paravertebral","Ecoguidado ou referências anatómicas","Agulha perpendicular, contacto com transversa e avançar 1-1.5 cm","Volume: 3-5 mL por nível (multi-nível) ou 15-20 mL (injeção única)","Cateter possível para analgesia prolongada"]}'::jsonb, '{"fr":["Ropivacaïne 0.5% (3-5 mL/niveau)","OU Bupivacaïne 0.25-0.5%","Perfusion continue: ropivacaïne 0.2% 5-10 mL/h"],"en":["Ropivacaine 0.5% (3-5 mL/level)","OR Bupivacaine 0.25-0.5%","Continuous infusion: ropivacaine 0.2% 5-10 mL/h"],"pt":["Ropivacaína 0.5% (3-5 mL/nível)","OU Bupivacaína 0.25-0.5%","Perfusão contínua: ropivacaína 0.2% 5-10 mL/h"]}'::jsonb, '[]'::jsonb),
('erector-spinae', 'trunk', '{"fr":"Bloc de l''érecteur du rachis (ESP block)","en":"Erector Spinae Plane (ESP) block","pt":"Bloqueio do eretor da espinha (ESP block)"}'::jsonb, '{"fr":["Chirurgie thoracique et abdominale","Fractures de côtes","Chirurgie du sein","Analgésie postopératoire multimodale","Alternative au paravertébral (plus sûr)"],"en":["Thoracic and abdominal surgery","Rib fractures","Breast surgery","Multimodal postoperative analgesia","Alternative to paravertebral (safer)"],"pt":["Cirurgia torácica e abdominal","Fraturas de costelas","Cirurgia da mama","Analgesia pós-operatória multimodal","Alternativa ao paravertebral (mais seguro)"]}'::jsonb, '{"fr":["Infection au site de ponction","Allergie aux anesthésiques locaux"],"en":["Infection at puncture site","Local anesthetic allergy"],"pt":["Infeção no local de punção","Alergia a anestésicos locais"]}'::jsonb, '{"fr":["Repère: apophyse transverse du niveau cible","Sonde linéaire, vue sagittale paravertébrale","Injection dans le plan fascial profond au muscle érecteur du rachis","Volume: 20-30 mL (diffusion crânio-caudale extensive)","Bloc superficiel = sécurité (pas de risque de pneumothorax)"],"en":["Landmark: transverse process at target level","Linear probe, paravertebral sagittal view","Injection in fascial plane deep to erector spinae muscle","Volume: 20-30 mL (extensive craniocaudal spread)","Superficial block = safety (no pneumothorax risk)"],"pt":["Referência: apófise transversa do nível alvo","Sonda linear, vista sagital paravertebral","Injeção no plano fascial profundo ao músculo eretor da espinha","Volume: 20-30 mL (difusão crânio-caudal extensa)","Bloqueio superficial = segurança (sem risco de pneumotórax)"]}'::jsonb, '{"fr":["Ropivacaïne 0.375% (20-30 mL)","OU Bupivacaïne 0.25% (20-30 mL)","Cathéter possible: ropivacaïne 0.2% 8-10 mL/h"],"en":["Ropivacaine 0.375% (20-30 mL)","OR Bupivacaine 0.25% (20-30 mL)","Catheter possible: ropivacaine 0.2% 8-10 mL/h"],"pt":["Ropivacaína 0.375% (20-30 mL)","OU Bupivacaína 0.25% (20-30 mL)","Cateter possível: ropivacaína 0.2% 8-10 mL/h"]}'::jsonb, '[]'::jsonb),
('scalp-block', 'head_neck', '{"fr":"Scalp block","en":"Scalp block","pt":"Bloqueio do escalpe"}'::jsonb, '{"fr":["Craniotomie éveillée","Craniotomie conventionnelle (analgésie)","Chirurgie de la voûte crânienne"],"en":["Awake craniotomy","Conventional craniotomy (analgesia)","Skull vault surgery"],"pt":["Craniotomia acordada","Craniotomia convencional (analgesia)","Cirurgia da calota craniana"]}'::jsonb, '{"fr":["Infection au site d''injection","Allergie aux anesthésiques locaux"],"en":["Infection at injection site","Local anesthetic allergy"],"pt":["Infeção no local de injeção","Alergia a anestésicos locais"]}'::jsonb, '{"fr":["Blocage de 6 nerfs bilatéraux: supra-orbitaire, supra-trochléaire, zygomatico-temporal, auriculo-temporal, grand occipital, petit occipital","Injection sous-cutanée au site de chaque nerf","Volume: 2-3 mL par nerf (total 25-35 mL)","Technique de repère anatomique ou échoguidée"],"en":["Block of 6 bilateral nerves: supraorbital, supratrochlear, zygomaticotemporal, auriculotemporal, greater occipital, lesser occipital","Subcutaneous injection at each nerve site","Volume: 2-3 mL per nerve (total 25-35 mL)","Anatomical landmark or ultrasound-guided technique"],"pt":["Bloqueio de 6 nervos bilaterais: supra-orbitário, supratroclear, zigomático-temporal, aurículo-temporal, grande occipital, pequeno occipital","Injeção subcutânea no local de cada nervo","Volume: 2-3 mL por nervo (total 25-35 mL)","Técnica de referência anatómica ou ecoguidada"]}'::jsonb, '{"fr":["Ropivacaïne 0.75% (2-3 mL/nerf)","OU Bupivacaïne 0.25% + adrénaline 1:200000","Dose totale: ne pas dépasser 3 mg/kg ropivacaïne"],"en":["Ropivacaine 0.75% (2-3 mL/nerve)","OR Bupivacaine 0.25% + epinephrine 1:200,000","Total dose: do not exceed 3 mg/kg ropivacaine"],"pt":["Ropivacaína 0.75% (2-3 mL/nervo)","OU Bupivacaína 0.25% + adrenalina 1:200.000","Dose total: não exceder 3 mg/kg ropivacaína"]}'::jsonb, '[]'::jsonb)
ON CONFLICT (id) DO NOTHING;

-- =============================================================
-- FIM — Dados completos AnesIA
-- =============================================================
